‹³Žö |
’†–{@ˆÀ¬ |
•½¬23”N1ŒŽ\ |
y‹³Žö |
à_–ì@’‰‘¥ |
•½¬2”N6ŒŽ\•½¬3”N3ŒŽC•½¬9”N7ŒŽ\•½¬9”N8ŒŽC •½¬10”N4ŒŽ\•½¬11”N3ŒŽC•½¬12”N4ŒŽ\ •½¬16”N3ŒŽC•½¬16”N4ŒŽ\•½¬18”N6ŒŽ(—¯Šw)C•½¬18”N7ŒŽ\i•½¬25”N4ŒŽ\Œ»Ej |
y‹³Žöi’nˆæ‚“xˆã—ÄiuÀj |
{“¡@O”V |
•½¬4”N6ŒŽ\•½¬5”N5ŒŽC•½¬7”N10ŒŽ\•½¬8”N3ŒŽC •½¬14”N4ŒŽ\•½¬14”N8ŒŽC•½¬14”N9ŒŽi—¯Šw)\•½¬16”N6ŒŽC•½¬16”N7ŒŽ\i•½¬25”N4ŒŽ|Œ»Ej |
• ‹³ |
ª–{@•üK |
•½¬16”N2ŒŽ\i•½¬22”N4ŒŽ|Œ»Ej |
• ‹³ |
‘å’J@¹O |
•½¬8”N4ŒŽ|•½¬9”N3ŒŽC•½¬14”N4ŒŽ|•½¬16”N9ŒŽC•½¬16”N10ŒŽi—¯Šwj|•½¬18”N9ŒŽC•½¬18”N10ŒŽi•½¬15”N9ŒŽ|Œ»Ej |
• ‹³ |
—Ñ@_Žk |
•½¬8”N4ŒŽ|•½¬9”N3ŒŽC•½¬11”N5ŒŽ|•½¬12”N4ŒŽC•½¬14”N5ŒŽ|•½¬15”N3ŒŽC•½¬26”N4ŒŽ|Œ»E |
• ‹³ |
ˆäì@³“¹ |
•½¬12”N5ŒŽ\•½¬13”N5C•½¬15”N4ŒŽ\•½¬17”N3ŒŽC•½¬18”N5ŒŽ\•½¬25”N10ŒŽC•½¬25”N11ŒŽi—¯Šwj\i•½¬22”N4ŒŽ|Œ»Ej |
• ‹³ |
¼‰i@»Žq |
•½¬14”N5ŒŽ|•½¬15”N4ŒŽC•½¬17”N4ŒŽ|i•½¬23”N4ŒŽ|Œ»Ej |
œ Œ¤‹†ŠT—v
“–—̈æ‚Å‚ÍŽå‚Æ‚µ‚ÄA1jÁ‰»ŠíƒOƒ‹[ƒvA2j_ŒoƒOƒ‹[ƒv‚É‚æ‚錤‹†‚ðŽÀŽ{‚µ‚Ä‚¢‚éB
œ –{Šw‚Ì—”O‚Æ‚ÌŠÖŒW
–{ŠwˆãŠw•”‚Ì—”O‚ÍA‘–¯«A‘Û«Aæi«A—Ï—«‚ÉŠî‚¢‚½ˆã—Â̋‰»‚Æ«—ˆ«‚ðŒ©’Ê‚µ‚½Œ¤‹†‚ÌŽÀs‚Ælވ笂ł ‚éB’S“–‚·‚鎾Š³‘Îۗ̈æ‚ÍA‚Ü‚³‚É‘–¯•a‚Æ‚¢‚¦‚鎾Š³‚Å‚ ‚éÁ‰»ŠíŠàA”]‘²’†A”F’mÇA_Œo“ï•a‚È‚Ç‚ðŽå‚Æ‚µ‚ÄŽæ‚舵‚Á‚Ä‚¨‚èA‘–¯‚ÌŒ’N‚Ì•ÛŒì‚Æ‘i‚ׂ̈Éf—ÃAŒ¤‹†‚ðs‚Á‚Ä‚¢‚éB‚Ü‚½‘“à‚Ì‘åŠw‚¨‚æ‚Ñ‘ŠO‚Ì‘åŠwŒ¤‹†Š(MIT,
Mayo Clinic)‚Æ‚Ì‹¤“¯Œ¤‹†‚¨‚æ‚Ñlތ𗬂às‚Á‚Ä‚¨‚èAŒ¤‹†‚Å‚Í¢ŠE‚Éæ‹ì‚¯V‚µ‚¢Ž–ŽÀ‚𖾂炩‚É‚µ‚Ä‚¢‚éB
‚±‚ê‚ç‚ÌŒ¤‹†‚ð’Ê‚µ‚Ä‘Û“I‚É’Ê—p‚·‚éæ’[ˆã—Â̊J”‚ð–ÚŽw‚µA‚³‚ç‚É‚Í‘–¯‘S‘Ì‚ÌŒ’N‘i‚ÉvŒ£‚·‚邱‚Æ‚ð–Ú•W‚Æ‚µ‚Ä‚¢‚éB
Á‰»Ší“à‰ÈƒOƒ‹[ƒv
œ Œ¤‹†ŠT—v
Á‰»Ší“à‰ÈƒOƒ‹[ƒv‚ÍA’†–{‹³Žöi‰È’·jA{“¡y‹³Žöi•›‰È’·jA•½¼y‹³ŽöAª–{•‹³A‘å’J•‹³A¼“c•‹³A“à“¡•a‰@•‹³‚ðƒXƒ^ƒbƒt‚Æ‚µ‚ÄAÁ‰»Ší“àŽ‹‹¾iãE‰º•”Á‰»ŠÇ“àŽ‹‹¾A’_äX“àŽ‹‹¾A’´‰¹”g“àŽ‹‹¾“™jA• •”’´‰¹”g‚ð—p‚¢‚½f’fEŽ¡—ÃŽè‹Z‚ðŽ{s‚µAŠeŽíÁ‰»ŠíŽ¾Š³‚ɑ΂µf’fEŽ¡—Âðs‚Á‚Ä‚¢‚éBŽå‚Èf—À–Ú‚Æ‚µ‚ÄA‚PjH“¹ŠàAˆÝŠàA‘å’°ŠàA‘å’°‘BŽî‚ɑ΂·‚é“àŽ‹‹¾“I”S–Œ‰º‘wØŠJ”—£piESDjA‚QjŠÌŠà‚ɑ΂·‚郉ƒWƒI”gÄŽÜpiRFAjA5-FU“®’/IFN•¹—p—Ö@A–Ɖu•â•—Ö@A‚RjÁ‰»ŠÇA’_äXŽ¾Š³‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‰ºúŽh‹zˆøpiEUS-FNAj‚ð—p‚¢‚½f’fEŽ¡—ÃA‚Sjis’_“¹Šà‚âäXŠà‚ɑ΂·‚é“àŽ‹‹¾“IŒ¸‰©Ž¡—ÃA‚TjHelicobacter
pyloriiH. pylorijŠ´õÇ‚Ìf’fEŽ¡—ÃA‚Uj¬’°Ž¾Š³‚ɑ΂·‚éƒJƒvƒZƒ‹“àŽ‹‹¾ŒŸ¸Aƒoƒ‹[ƒ““àŽ‹‹¾ŒŸ¸A‚VjBŒ^ŠÌ‰ŠACŒ^ŠÌ‰Š‚ɑ΂·‚éRƒEƒCƒ‹ƒXŽ¡—ÂȂǂðs‚Á‚Ä‚¢‚éB
•½¬16”N10ŒŽ‚©‚ç‚͈݊à‚ɑ΂·‚éƒI[ƒ_[ƒƒCƒhˆã—Â̈êŠÂ‚Æ‚µ‚ÄAê–åŠO—ˆ‚Æ‚µ‚Ä‚ÌuƒsƒƒŠŠO—ˆv‚ðŠJÝ‚µAÅ‹ß‚Å‚ÍŽOŽŸœ‹ÛŽ¡—ÂðÏ‹É“I‚És‚Á‚Ä‚¢‚éB‚Ü‚½AŽèp•s”\ŠÌ×–EŠà‚ɑ΂·‚éŠÌ“®–¬Çð—Ö@iTAEj‚ÆŽ÷ó×–E–ƉuŽ¡—ÂÌæiˆã—Âð–ÚŽw‚µ‚½—Õ°ŽŽŒ±‚ðŠJŽn‚µAÁ‰»ŠíŠà‚ɑ΂·‚éV‚½‚ÈŽ¡—Ö@‚ÌŠJ”‚É’§í‚µ‚Ä‚¢‚éB
Žå‚ÈŒ¤‹†ƒe[ƒ}‚ÍA‚PjH. pyloriŠ´õ‚É‚¨‚¯‚éÁ‰»ŠíŽ¾Š³‚Ì—Õ°•a‘Ô‰ðÍ‚È‚ç‚Ñ‚ÉH.pylori‹Û‘Ì•aŒ´ˆöŽq‚ÆhŽå–Ɖu”½‰ž‚̉ðÍA‚Qj—«ƒzƒ‹ƒ‚ƒ“‚̈ݔŠà—}§ì—p‚̉ðÍA‚Rj—Î’ƒƒJƒeƒLƒ“A–hŒäˆöŽq»Ü‚Ȃǂ̈ݔŠà—}§ì—p‚̉ðÍA‚SjNSAIDs‹Nˆö«Á‰»ŠÇ”S–ŒáŠQ‚Ì•a‘Ô‰ðÍA‚Tjƒ}ƒCƒNƒƒLƒƒƒrƒeƒBƒAƒŒƒC‰t‘̶ŒŸ‹Zp‚ð—p‚¢‚½ŠÌ‚ª‚ñÄ”’´‘Šúf’f–@‚ÌŠJ”A‚UjŠÌ‰Š‚É‚¨‚¯‚émiRNA‚̉ðÍA‚VjCŒ^ŠÌ‰ŠŠ³ŽÒ‚É‚¨‚¯‚éHLA-class‡U—̈æ‚ÌSNP‰ðÍA‚WjŠÌ×–EŠà‚ɑ΂·‚鎡—Ê´Žó«ˆöŽq‚Ì’TõA‚X) ƒ‰ƒWƒI”gÄŽÜ‚¨‚æ‚ÑTAEŒãƒAƒWƒ…ƒoƒ“ƒh“Š—^‚É‚æ‚éŠÌŠà–Ɖu•â•—Ö@‚ÉŠÖ‚·‚é—Õ°Œ¤‹†A‚P‚O) ŠÌƒGƒlƒ‹ƒM[‘ãŽÓ‚ÉŠÖ—^‚·‚éV‹K“]ŽÊ—}§ˆöŽq‚Ì‹@”\‰ðÍA‚P‚P) Ž©ŒÈ–Ɖu«ŠÌ‰Š‚ÉŠÖ—^‚·‚é“]ŽÊ’²ßˆöŽq‚̉ðÍA‚P‚QjBŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚Ì•a‘Ô‰ðÍ‚È‚Ç‚Å‚ ‚éB
œ ƒL[ƒ[ƒh
ŠÌ‰Š, ŠÌŠà,
Helicobacter pyloriŠ´õÇ
œ ‹ÆÑ”N‚Ìi’»ó‹µ
‚±‚±””N‚ÌŠî‘bŒ¤‹†E—Õ°Œ¤‹†‚̬‰Ê‚ð•Ä‘ŠÌ‘ŸŠw‰ï‹ciAASLDjA‰¢BÁ‰»Ší•aTŠÔiUEGWjA“ú–{Á‰»Ší•aŠw‰ïA“ú–{ŠÌ‘ŸŠw‰ï‚È‚Ç‚Ì‘“àŠO‚ÌŠw‰ï‘‰ï‚È‚Ç‚Å”•\‚µ‚½B‚Ü‚½AisŠÌŠà‚É‚¨‚¯‚鎡—ÑI‘ð‚ɂ‚¢‚ÄŒ´’˜˜_•¶‚Æ‚µ‚Ä”•\‚µAESD‚ðŽ{s‚µ“¾‚½‹H‚È•\ÝŒ^H“¹—ÞŠî’ê×–EŠà‚Ì1—á‚ɂ‚¢‚ÄÇ—á•ñ‚Æ‚µ‚Ę_•¶”•\‚µ‚½B
œ “ÁF“™
“–‰È‚Å‚ÍH.
pylori—Õ°•ª—£Š”‚̈â“`Žq‰ðÍ‚¨‚æ‚уKƒXƒgƒŠƒ“ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚ð—p‚¢‚½Š´õŽÀŒ±‚ð’Ê‚µ‚ÄAH.
pyloriŠ´õ‚É‚¨‚¯‚éˆÝ”Šà‹@\‚̉ðÍ‚ðs‚¤‚Æ‚Æ‚à‚ÉA—Õ°•a‘Ô‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚ĉðÍ‚ðs‚Á‚Ä‚«‚½B¡ŒãAH.
pyloriŠ´õÇ‚¨‚æ‚ъ̉ŠAŠÌŠà‚Ì•a‘Ô‰ðÍ‚ðs‚¢AÁ‰»ŠíŠà‚É‚¨‚¯‚鉊ǔŠà‚Ì•ªŽq‹@\‚̉𖾂Ƃ»‚ÌŽ•ž‚ð–Ú•W‚ÉŒ¤‹†‚ði‚ß‚é—\’è‚Å‚ ‚éB
_Œo“à‰ÈƒOƒ‹[ƒv
œ Œ¤‹†ŠT—v
_Œo“à‰ÈƒOƒ‹[ƒv‚ÍAà_–ìy‹³Žöi‰È’·jAŽR‘ºuŽti•›‰È’·jAˆäì•‹³A¼‰i•‹³‚ðƒXƒ^ƒbƒt‚Æ‚µ‚Ĉȉº‚ÌŒ¤‹†ƒe[ƒ}‚ÉŽæ‚è‘g‚ñ‚Å‚¢‚éB‚Pjƒ~ƒgƒRƒ“ƒhƒŠƒA•a‚̈ê‚‚ÌMELASŠ³ŽÒ‚âƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚¨‚¯‚éƒGƒlƒ‹ƒM[‘ãŽÓEŽ_‰»ƒXƒgƒŒƒX‚Ì”]‹@”\ƒCƒ[ƒWƒ“ƒOiMRIAPETji‚ƒGƒlƒ‹ƒM[Œ¤‚¨‚æ‚Ñ•úŽË«ˆãŠwŒ¤‹†Š‚Æ‚Ì‹¤“¯Œ¤‹†A•¶‰ÈÈŒ¤‹†”ÇjA‚QjMELAS”]‘²’†”쎞‚ÌV–ò‚Å‚ ‚éL-ƒAƒ‹ƒMƒjƒ“‚Ì—Õ°Œø‰Ê‚â–ò—ì—p‚ÌŒŸ“¢i‹v—¯•Ä‘嬎™‰È‚Æ‚Ì‹¤“¯Œ¤‹†AŒú˜JȔnj¤‹†jA‚RjƒvƒƒeƒI[ƒ€‰ðÍ‚ð—p‚¢‚½‹´–{”]Ç‚ÌŽ©ŒÈR‘Ì‚Ì“¯’è‚Æ•a‘Ԃ̉ðÍiŒú˜JÈ‚¨‚æ‚Ñ•¶‰ÈÈŒ¤‹†”ÇjA‚SjƒAƒ‹ƒcƒnƒCƒ}[•a‚Ì•aˆö‚ÉŠÖ‚í‚éƒ^ƒE’`”’‚̃Šƒ“Ž_‰»¥d‡‹@\‚ÌŒŸ“¢‚ÆŽ¡—Öò‚ÌŠJ”iMayo
Clinic Jacksonville‚Æ‚Ì‹¤“¯Œ¤‹†A•¶‰ÈÈŒ¤‹†”ÇjA‚¨‚æ‚ÑŽ¡—Öò‚ÌŒø‰Ê‚Ì—Õ°“IŒŸ“¢A‚Tj”F’mÇ‚É‚¨‚¯‚éƒrƒ^ƒ~ƒ“Œ‡–R‚ÌŒ¤‹†A‚Uj‘å”]”玿Šî’êŠj•Ï«Ç‚ɑ΂·‚éCDP-Choline‚ÌŽ¡—ÃŒø‰Ê‚Ì”»’èi‚ƒGƒlƒ‹ƒM[Œ¤‚Æ‚Ì‹¤“¯Œ¤‹†jA‚Vj_Œo‹ØŽ¾Š³‚Ì‹ØMRIŠŒ©‚ÌŒŸ“¢(•úŽËü‰È‚Æ‚Ì‹¤“¯Œ¤‹†)A‚Wjד®–¬d‰»‚Ì•]‰¿Žw•W‚ÉŠÖ‚·‚錤‹†iŒú˜JÈŒ¤‹†”ÇjA‚Xjˆã—ÃIT‚ð—p‚¢‚½_ŒoŽ¾Š³‚Ì’nˆæ˜AŒg‚ÉŠÖ‚·‚錤‹†A‚P‚OjBrain
Machine Interface(BMI)Œ¤‹†i“d‹C’ÊM‘åŠw‚Æ‚Ì‹¤“¯Œ¤‹†j‚È‚Ç‘½”s‚Á‚Ä‚¢‚Ü‚·B
œ ƒL[ƒ[ƒh
ƒ~ƒgƒRƒ“ƒhƒŠƒA•a, ‹´–{”]Ç, ƒAƒ‹ƒcƒnƒCƒ}[•a, ƒp[ƒLƒ“ƒ\ƒ“•a, ”]ŒŒŠÇáŠQ
œ ‹ÆÑ”N‚Ìi’»ó‹µ
ƒ~ƒgƒRƒ“ƒhƒŠƒA•a‚¨‚æ‚уp[ƒLƒ“ƒ\ƒ“•aA‚¨‚æ‚ÑALS‚É‚¨‚¯‚éPET‚ð—p‚¢‚½Ž_‰»ƒXƒgƒŒƒX‚Ì”]‹@”\ƒCƒ[ƒWƒ“ƒO‚ɉ‚߂ĬŒ÷‚µ‚½BƒvƒƒeƒI[ƒ€‰ðÍ‚ð—p‚¢‚Ä“¯’肵‚½‹´–{”]ÇŠ³ŽÒ‚Ìf’fƒ}[ƒJ[iRNAER‘Ìj‚ÍA‘“àŠO‚©‚ç”NŠÔ300ŒˆÈã‚̉ð͈˗Š‚ª‚ ‚èA–{Ž¾Š³‚Ìf’f‚É•K{‚Æ‚È‚Á‚Ä‚«‚½BƒXƒ^ƒ`ƒ“A‚o‚o‚`‚qƒÁƒAƒSƒjƒXƒgAROCK‘jŠQ–ò‚ðŽn‚ß‚Æ‚µ‚½ŠeŽí–òÜ‚É‚æ‚éTau’`”’ƒŠƒ“Ž_‰»—}§Œø‰Ê‚ª”|—{×–E‚Å–¾‚ç‚©‚Æ‚È‚Á‚½Bƒrƒ^ƒ~ƒ“‚a12A—tŽ_Œ‡–RÇ‚ª‚ƒzƒ‚ƒVƒXƒeƒBƒ“ŒŒÇ‚ð‚Ђ±‚¨‚±‚µA”F’m‹@”\‚ðˆ«‰»‚³‚¹‚邱‚Æ‚ðŽ¦‚µ‚½B‚³‚ç‚Ƀzƒ‚ƒVƒXƒeƒCƒ“‚É‚æ‚èƒ^ƒE’`”’‚Ìd‡‚ð‘£i‚·‚é‹@˜‚ð‰ð–¾‚µ‚½B‚Ü‚½–«”]’ázŠÂƒ}ƒEƒXƒ‚ƒfƒ‹‚ð—p‚¢Aƒ^ƒE‚̃Šƒ“Ž_‰»‘£i‚ðØ–¾‚Å‚«‚½B‹¤’ʂ̃NƒŠƒeƒBƒJƒ‹ƒpƒX‚È‚Ç‚ð—p‚¢‚½”]‘²’†‚Ì’nˆæ˜AŒg‚ª„i‚³‚êA‘S‘‚̃‚ƒfƒ‹ƒP[ƒX‚Æ‚µ‚Ä’–Ú‚³‚ê‚Ä‚¢‚éB‹Ø‹’¼«ƒWƒXƒgƒƒtƒB[Š³ŽÒ‚Ì㎈MRIŠŒ©‚ÌŒŸ“¢‚É‚æ‚èáŠQ‹Ø‚ð‰‚ß‚Ä“¯’è‚Å‚«‚½B
œ “ÁF“™
”]‘²’†AƒAƒ‹ƒcƒnƒCƒ}[•a‚âƒp[ƒLƒ“ƒ\ƒ“•a‚È‚Ç‚Ì‚È‚Ç‚Ì_Œocommon
disease‚©‚çƒ~ƒgƒRƒ“ƒhƒŠƒA•aA‘å”]”玿Šî’êŠj•Ï«Ç‚ð‚Í‚¶‚ß‚Æ‚·‚é_Œo“ï•a‚Ì•a‘Ô‚ÆŽ¡—ÂɊւµ‚ÄAˆâ“`ŽqAƒvƒƒeƒIƒ~ƒNƒXA”|—{×–E‚ð—p‚¢‚½Šî‘b“IŒ¤‹†‚©‚çAPET‚âMRI‚ð—p‚¢‚½Š³ŽÒ‚Ì•a‘Ô‰ðÍ‚Ü‚Å•L‚¢Œ¤‹†‚ðs‚Á‚Ä‚¢‚éB‚Ü‚½A—Õ°’nˆæ˜AŒg‚Ì\’z‚Ȃǂ̈ã—ÃVƒXƒeƒ€‚ÉŒW‚錤‹†‚às‚Á‚Ä‚¢‚éB
‹æ@@•ª |
•Ò@@” |
ƒCƒ“ƒpƒNƒgƒtƒ@ƒNƒ^[ (‚¤‚¿Œ´’˜‚Ì‚Ý) |
|||
2009`2014”N•ª |
2014”N•ª |
2009`2014”N•ª |
2014”N•ª |
||
˜a•¶Œ´’˜˜_•¶ |
30 |
4 |
\\\\\ |
\\\\\ |
|
‰p•¶˜_•¶ |
̧°½Äµ°»° |
21 |
3 |
59.406 ( 59.406) |
2.773 ( 2.773) |
ºÚ½ÎßÝÃިݸ޵°»° |
16 |
2 |
36.546 ( 36.546) |
0.000 ( 0.000) |
|
‚»‚Ì‘¼ |
43 |
6 |
160.840 ( 159.116) |
13.100 ( 11.376) |
|
‡Œv |
66 |
9 |
222.938 ( 221.214) |
15.873 ( 14.149) |
iAj ’˜‘E˜_•¶“™
(1)
‰p•¶F˜_•¶“™
aDŒ´’˜˜_•¶iR¸—Lj
1429000
+H.Nakagawa, +E.Mizukoshi, +N.Iida, +T.Terashima,
+M.Kitahara, +Y.Marukawa, +K.Kitamura, Y.Nakamoto, +K.Hiroishi, +M.Imawari, +S.Kaneko:
In vivo immunological antitumor effect of OK-432-stimulated dendritic cell
transfer after radiofrequency ablation. Cancer Immunol Immunother, 63i4j,
347-356, 2014.04, #3.943
1429001
*Takahisa Kawano, +Kohei Hasegawa, +Hiroko Watase, *H,Morita, O.Yamamura: Infectious Disease Frequency Among
Evacuees at Shelters After the Great Eastern Japan Earthquake and Tsunami:A
Retrospective Study. Disaster Medicine and Public Health Preparedness, 2014.04,
#1.142
1429002
+T.Muramatsu, M.Ikawa, *M.Yoneda,
*K.Sugimoto, A.Matsunaga, O.Yamamura, T. Hamano, *H.Okazawa, Y.Nakamoto:
Pathophysiological decrease in the regional cerebral blood flow in Hashimotofs
encephalopathy: a multiple-case SPECT study. Eur Neurology, 72i1-2j,
13-19, 2014.07, #1.362
1429003
+M.Kitahara, +E.Mizukoshi, Y.Nakamoto,
+N.Mukaida, +K.Matsushima, +S.Kaneko: Efficient generation of highly
immunocompetent dendritic cells from peripheral blood of patients with
hepatitis C virus-related hepatocellular carcinoma. Int Immunopharmacol, 21i2j,
346-353, 2014.08, #2.711
1429004
+T.Yamashita, +A.Kitao, +O.Matsui, +T.Hayashi,
+K.Nio, +M.Kondo, +N.Ohno, +T.Miyati, +H.Okada, +T.Yamashita, +E.Mizukoshi,
+M.Honda, +Y.Nakanuma, +H.Takamura, +T.Ohta, Y.Nakamoto, +M.Yamamoto,
+T.Takayama, +S.Arii, +X.Wang, +S.Kaneko: Gd-EOB-DTPA-enhanced magnetic
resonance imaging and alpha-fetoprotein predict prognosis of early-stage
hepatocellular carcinoma. Hepatology,
60i5j, 1674-1685, 2014.11, #11.190
1429005
T.Nemoto, *H.Matsuda, T.Nosaka, Y.Saito,
Y.Ozaki, R.Hayama, T.Naito, K.Takahashi, K.Ofuji, M.Ohtani, *K.Hiramatsu,
H.Suto, Y.Nakamoto: Comparison of hepatic
arterial infusion chemotherapy and sorafenib in elderly patients with advanced
hepatocellular carcinoma: A case series. Mol Clin Oncol, 2i6j,
1028-1034, 2014.11
1429006
+Y.Miyake, +K.Yamamoto, +H.Matsushita, +M.Abe,
+A.Takahashi, +T.Umemura, +A.Tanaka, +M.Nakamuta, Y.Nakamoto, +Y.Ueno,
+T.Saibara, +H.Takikawa, +K.Yoshizawa, +H.Ohira, +M.Zeniya, +M.Onji, +H.Tsubouchi:
Multicenter validation study of anti-programmed cell death-1 antibody as a
serological marker for type 1 autoimmune hepatitis.
Hepatol Res, 44i13j,
1299-1307, 2014.12, #2.218
1429007
K.Ofuji, +Y.Tada, +T.Yoshikawa, +M.Shimomura,
+M.Yoshimura, +K.Saito, Y.Nakamoto, +T.Nakatsura: A peptide antigen
derived from EGFR T790M is immunogenic in non‑small cell lung cancer. Int J
Oncol, 46i2j, 497-504, 2015.02, #2.773
1429008
Y.Ozaki, H.Suto, T.Nosaka, Y.Saito, T.Naito,
K.Takahashi, K.Ofuji, *H.Matsuda, M.Ohtani, *K.Hiramatsu, T.Nemoto, *Y.Imamura,
Y.Nakamoto: A case of Helicobacter pylori-negative intramucosal
well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J
Gastroenterol, 8i1j,
18-21, 2015.02iÇ—á•ñj
bD‘à
1429009
*H.Okazawa, M.Ikawa, *T.Tsujikawa, *Y.Kiyono,
M.Yoneda: Brain imaging for oxidative stress and mitochondrial dysfunction in
neurodegenerative disease. Q J Nucl Med Mol Imaging, 58i4j,
387-397, 2014.12, #1.724
(2)
˜a•¶F’˜‘“™iproceedings‚ðœ‚j
aD’˜‘i•ª’SŽ·•Mj
1429010
ˆäì@³“¹, +•Ä“c@½:
MERRF: ™]G•v(‘•ÒW)C•Ÿ“c“~‹GŽqE¼–ìˆêŽOEŒÃ‰ê–õ•q(•ª’S•ÒW)(•Ò): ‘ãŽÓ«ƒ~ƒIƒpƒ`[, f’f‚ÆŽ¡—ÃŽÐ,
175-177, 2014.05
1429011
*•Ä“c@½, ˆäì@³“¹, *‰ª‘ò@G•F:
8. ƒp[ƒLƒ“ƒ\ƒ“•a‚¨‚æ‚ÑŠÖ˜A_ŒoŽ¾Š³‚ÌPETŽ_‰»ƒXƒgƒŒƒXƒCƒ[ƒWƒ“ƒO: ‚‹´—Ç•ãAŽ½’J@^AŽR’†G“ñA”óŒû^l(•Ò): ˆâ“`ŽqˆãŠwMOOK 26: ”]“àŠÂ‹«-ˆÛŽ‹@\‚Æ”j’]‚ª‚à‚½‚ç‚·Ž¾Š³Œ¤‹†, 1, ƒƒfƒBƒJƒ‹ ƒhƒD,
212-215, 2014.11
1429012
Ö“¡@—L‹I, ¼‰i@»Žq, +•Ä“c@½: ƒgƒLƒ\ƒvƒ‰ƒYƒ}”]‰Š: _ŒoŠ´õÇ‚ð‹†‚ß‚é ƒAƒNƒ`ƒ…ƒAƒ‹ ”]E_ŒoŽ¾Š³‚Ì—Õ°, ’†ŽR‘“X,
240-244, 2014
bD–|–ó“™i•ª’S–|–ój
1429013
’†–{@ˆÀ¬(–ó):
BŒ^ŠÌ‰Š‚ÌŒŒ´ƒ}[ƒJ[‚ÌŽ©‘RŒo‰ß‚Å‚ÌRŒ´‰A«‰»‚Æ‚»‚ÌŒã‚ÌŠÌ×–EŠà‚̃ŠƒXƒN: GUT“ú–{Œê”ÅVol.6,No.5,
WILEY Blackwell, 16-17, 2015.01
(3)
˜a•¶F˜_•¶“™
aDŒ´’˜˜_•¶iR¸—Lj
1429014
–ìã@‘ñl, {“¡@O”V, *¼“c@GŠx, ‚‹´@˜al, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, *¡‘º@DÍ, ’†–{@ˆÀ¬: “àŽ‹‹¾“I”S–Œ‰º‘w”—£p‚ÅØœ‚µ“¾‚½•\ÝŒ^H“¹—ÞŠî’ê×–EŠà‚Ì1—á. “ú–{Á‰»Ší•aŠw‰ïŽGŽ,
111i6j, 1005-1112, 2014.06iÇ—á•ñj
1429015
âV“¡@—L‹I, ¼‰i@»Žq, ŽR‘º@C, ˆäì@³“¹, ûM–ì@’‰‘¥, +•Ä“c@½: ”]—À–c‘å•”‰E‘¤[Ç‚É‚æ‚趔¼‘¤‘Š–e•ÏŒ`Ž‹‚ð‚«‚½‚µ‚½¶‚«‚«‚Ì1—á. —Õ°_ŒoŠw,
54i8j, 637-642, 2014.08iÇ—á•ñj
1429016
“à“¡@’BŽu, {“¡@O”V, –ìã@‘ñl, ꎓ¡@‹±Žu, ”öú±@‰Ã•F, ‚‹´@˜al, ‘å“¡@˜a–ç, ‘å–ì@’, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, *¡‘º@DÍ, ’†–{@ˆÀ¬: •úŽËü—Ö@‚ª’˜Œø‚µ‚½Helicobacter
pyloriœ‹ÛŽ¡—Ã’ïR«’¼’°MALTƒŠƒ“ƒpŽî‚Ì1—á.
ENDOSCOPIC FORUM for digestive disease, 30i2j,
131-136, 2014.11iÇ—á•ñj
1429017
_àV@•üŽq, ˆäì@³“¹, ûM–ì@’‰‘¥, +‰i“c@”ü˜aŽq, *–Ø‘º@_•F, •Ä“c@½: ”ÇŽž‚̃Jƒ‹ƒ{ƒLƒVƒwƒ‚ƒOƒƒrƒ“‚ª³í‚Å‚ ‚Á‚½‚ª“ª•”MR
spectroscopyŠŒ©‚ªf’f‚ÌŒ_‹@‚Æ‚È‚Á‚½ŠÔŸ[Œ^ˆêŽ_‰»’Y‘f’†“Å‚Ì1—á. —Õ°_ŒoŠw,
54i3j, 234-237, 2014iÇ—á•ñj
bD‘à
1429018
’†–{@ˆÀ¬: BŒ^–«ŠÌ‰Š‚ðŽ©‘R”Ç‚µ‚½ƒ‚[ƒŠƒVƒƒƒX“‡ƒJƒjƒNƒCƒUƒ‹‚Ì”Œ©‚Æ—Õ°“IˆÓ‹`.
Frontiers in Gastroenterology, 19i2j,
46-47, 2014.04
1429019
{“¡@O”V, ’†–{@ˆÀ¬:
Helicobacter pyloriŠ´õ‚ɑ΂·‚é‘å‹K–Íœ‹ÛŽ¡—Â̗˜“_F’nˆæZ–¯‚ð‘ÎÛ‚Æ‚µ‚½ˆÝŠà—\–h‚ÌŒ¤‹†.
Frontiers in Gastroenterology, 19i2j,
48-49, 2014.04
1429020
ª–{@•üK, ’†–{@ˆÀ¬: –«ŠÌáŠQ‚É‚æ‚éŠÌ”Šàƒ‚ƒfƒ‹‚É‚¨‚¢‚Äp53‚Í”ñ×–EŽ©—§“I‚ÉŽîᇗ}§‚É“‚.
Frontiers in Gastroenterology, 19i2j,
50-51, 2014.04
1429021
*•½¼@ŠˆŽu, ’†–{@ˆÀ¬: ’×ᇫ‘å’°‰Š‚É‚¨‚¢‚Ä,GWAS‚ÅŽw“E‚³‚ꂽˆâ“`ŽqÀ‚ðÄ“xƒfƒB[ƒvƒV[ƒNƒGƒ“ƒX‚·‚é‚Æ,CARD9,IL23R,RNF186—̈æ‚ÌŠó•ÏˆÙ‚ªŽ¾Š³‚ÆŠÖ˜A‚µ‚Ä‚¢‚邱‚Æ‚ª‚í‚©‚Á‚½.
Frontiers in Gastroenterology, 19i2j,
52-53, 2014.04
1429022
‘å’J@¹O, ’†–{@ˆÀ¬:
IgG4ŠÖ˜Ad‰»«’_ŠÇ‰ŠŠ³ŽÒ’_`’†‚Ì‘‰Á‚µ‚½Th2ƒTƒCƒgƒJƒCƒ“‚̓^ƒCƒgƒWƒƒƒ“ƒNƒVƒ‡ƒ“‚É‚æ‚é’_ŠÇã”ç×–EƒoƒŠƒA‚ðáŠQ‚·‚é.
Frontiers in Gastroenterology, 19i2j,
54-55, 2014.04
1429023
¼‰i@»Žq, •Ä“c@½: ‰“Šu_Œonj󂩂ç‚Ý‚½ˆ««Žîá‡u¬”]«‰^“®Ž¸’²v. ¬l•a‚ƶŠˆKŠµ•a
‚±‚ñ‚È_ŒoÇó‚©‚çŽn‚܂鈫«Žîá‡-–TŽîá‡ÇŒóŒQ‚ÌŽÀ‘Ô-, 44i4j,
401-405, 2014.04
1429024
_àV@•üŽq, +•Ä“c@½: ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX_ŒoŠ´õÇ-ƒKƒCƒhƒ‰ƒCƒ“‚ðŠÜ‚ß‚Ä-. ÅVˆãŠwE•Êû
V‚µ‚¢f’f‚ÆŽ¡—ÂÌABC 82, 155-166, 2014.04
1429025
ª–{@•üK, ’†–{@ˆÀ¬: ŠÌ\¬×–E‚ƖƉu.
Hepatology Practice‘æ4Šª@“«ŠÌŽ¾Š³‚Ìf—Âð‹É‚ß‚é@Šî–{‚©‚çÅ‘Oü‚Ü‚Å,
8-11, 2014.05
1429026
*rì@Œ’ˆê˜Y, ˆäì@³“¹, +•Ä“c@½: ƒ~ƒgƒRƒ“ƒhƒŠƒAS‹ØÇ‚Æ‘ãŽÓŽ¡—Ã. ŒŽŠ§@×–E,
46i7j, 22-25, 2014.07
1429027
’†–{@ˆÀ¬, ª–{@•üK: –Ɖu—Ö@.
Hepatology Practice‘æ5Šª@ŠÌŠà‚Ìf—Âð‹É‚ß‚é@Šî–{‚©‚çÅ‘Oü‚Ü‚Å,
5, 328-331, 2014.09
1429028
¼‰i@»Žq, •Ä“c@½: bó‘B‹@”\˜´iÇ. •Êû“ú–{—Õà¬
V—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.30 _ŒoÇŒóŒQ(‘æ2”Å)V-‚»‚Ì‘¼‚Ì_ŒoŽ¾Š³‚ðŠÜ‚ß‚Ä-,
214-218, 2014.11
1429029
‰|–{@’ˆê, ¼‰i@»Žq, •Ä“c@½: bó‘B‹@”\’ቺÇ. •Êû“ú–{—Õà¬
V—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.30 _ŒoÇŒóŒQ(‘æ2”Å)V-‚»‚Ì‘¼‚Ì_ŒoŽ¾Š³‚ðŠÜ‚ß‚Ä-,
219-223, 2014.11
1429030
*¼“c@GŠx, ’†–{@ˆÀ¬: ŠÌ”^á‡CÅ‹ß‚ÌŽ–î. f’f‚ÆŽ¡—Ã
ŠÌ‘Ÿ•af—ẪAƒbƒvƒf[ƒg, 102i11j,
1701-1705, 2014.11
1429031
ûM–ì@’‰‘¥: ‰¡–ä‹Ø—Z‰ðÇ. •Êû“ú–{—Õà¬
V—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY‡‚30@_ŒoÇŒóŒQi‘æ2”ÅjV,
30, 598-602, 2014.11
1429032
ˆäì@³“¹, •Ä“c@½:
MERRF(ÔF‚Ú‚ëüˆÛ‚𔺂¤ƒ~ƒIƒNƒ[ƒkƒX‚Ä‚ñ‚©‚ñÇŒóŒQ). •Êû“ú–{—ÕଠV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo.31
_ŒoÇŒóŒQ(‘æ2”Å)‡Y-‚»‚Ì‘¼‚Ì_ŒoŽ¾Š³‚ðŠÜ‚ß‚Ä-,
345-348, 2014.12
1429033
+ŠÛì@—m•½, ’†–{@ˆÀ¬, +Œü“c@’¼Žj, +‹àŽq@Žüˆê: Ž©ŽEˆâ“`ŽqŽ¡—ƒP‹…‘–‰»«ƒ^ƒ“ƒpƒNŽ¿-1.
“ú–{—Õ଑Š§† ÅVŠÌŠàŠw-Šî‘b‚Æ—Õ°‚ÌÅVŒ¤‹†“®Œü-,
73i1j, 413-417, 2015.01
cD‚»‚Ì‘¼Œ¤‹†“™ŽÀÑi•ñ‘‚ðŠÜ‚Þj
1429034
+”ª‹´@O, ’†–{@ˆÀ¬:
11th Single Topic Conference@’ƒŽR ˆê² ‰ï’·‚É•·‚. ŠÌ‘Ÿ,
55i7j, 375-377, 2014.07
1429035
’†–{@ˆÀ¬: ‹¤“¯Œ¤‹†ŽÒ‚ÌЉî. ‹à‘ò‘åŠw‚ª‚ñi“W§ŒäŒ¤‹†Š
News Letter ‘nŠ§†, 8, 2014.10
iBj Šw‰ï”•\“™
(1) ‘ÛŠw‰ï
aDˆê”Êu‰‰iŒû‰‰j
1429036
T.Hamano, N.Shirafuji, +S.H.Yen, *A.Ishida,
+Y.Fujita, A.Matsunaga, O.Yamamura, +M.Kuriyama, Y.Nakamoto: ROCK inhibitor
decreases phosphorylation levels of tau protein, 26th International Conference
of Alzheimer's Association International ConferenceiAAIC
2014), 2014.07, Copenhagen,Denmark
1429037
*K.Hiramatsu, *H.Matsuda, M.Ohtani, T.Nemoto,
H.Suto, Y.Nakamoto: EFFECTIVENESS AND SAFETY OF ENDOSCOPIC SUBMUCOSAL
DISSECTION USING THE BALL-TIP BIPOLARCURRENT NEEDLE KNIFE WITH WATER-JET
FUNCTION (JET B-KNIFE) FOR THE TREATMENT OF COLORECTAL TUMORS, 22nd United
European Gastroenterology Week, 2014.10, Vienna,Austria
bDˆê”Êu‰‰iƒ|ƒXƒ^[j
(1329103)
+T.Yamashita, +A.Kitao, +O.Matsui, +T.Hayashi,
+K.Nio, +M.Kondo, +H.Okada, +T.Yamashita, +E.Mizukoshi, +M.Honda, +Y.Nakanuma,
+H.Takamura, +T.Ohta, Y.Nakamoto, +M.Yamamoto, +T.Takayama, +S.Arii, +X.Wang,
+S.Kaneko: Gd-EOB-DTPA-enhanced MRI and Serum AFP Predict the Prognosis of
Early-stage Hepatocellular Carcinoma, The 64th Annual Meeting of the American
Association for the Study of Liver Diseases(AASLD2013), 2013.11, Washington,
D.C.
1429038
A.Matsunaga, T.Kishitani, T.Muramatsu, *T.Kame,
M.Ikawa, O.Yamamura, T.Hamano, Y.Nakamoto, +M.Yoneda: Clinical and
immunological features of Hashimotofs encephalopathy presenting with limbic
symptoms, 2014 AAN, 2014.04, Philadelphia
1429039
*M.Hasegawa, +M.Yoshikawa, O.Yamamura,
*H.Terasawa: Difficulties identified by at-home care providers working with
multidisciplinary professionals, 35‚”‚ˆ International
Association for Human Caring Conference, 2014.05, Kyoto(Japan)
1429040
+M.Yoshikawa, *M.Hasegawa, O.Yamamura,
*H.Terasawa: Difficulties of cooperation recognized by at-home care providers
/givers |To clarify the content of trainings about how multidisciplinary
professionals work together|, 35‚”‚ˆ
International Association for Human Caring Conference, 2014.05
1429041
T.Kamisawa, M.Ikawa, +Y.Saito, T.Muramatsu,
A.Matsunaga, O.Yamamura, T.Hamano, Y.Nakamoto, +S.Murayama, *H.Okazawa,
+M.Yoneda: Pathophysiological decrease in the regional cerebral blood flow in
pure autonomic failure with Lewy body, 2014 AAN, 2014.05, Philadelphia
1429042
M.Ikawa, *H.Okazawa, *T.Tsujikawa,
T.Muramatsu, T.Kishitani, T.Kamisawa, A.Matsunaga, O.Yamamura, *T.Mori,
T.Hamano, *Y.Kiyono, Y.Nakamoto, +M.Yoneda: Increased cerebral oxidative stress
in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study, 2014 AAN, 2014.05,
Philadelphia
1429043
*H.Okazawa, M.Ikawa, *T.Tsujikawa, A.Matsunaga,
*T.Mori, *Y.Kiyono, *M.Yoneda: Evaluation of cerebral oxidative stress in
amyotrophic lateral sclerosis using 62Cu-ATSM PET., The 61st Annual
Meeting of The Society of Nuclear Medicine, 2014.06, St. Louis (USA)
1429044
+Y.Fujita, T.Hamano, N.Shirafuji, Y.Nakamoto:
Chronic cerebral hypoperfusion induces tau hyperphosphorylation accompanied by
axonal damage in adult mice, 26th International Conference of Alzheimer's
Association International ConferenceiAAIC 2014),
2014.07, Copenhagen,Denmark
1429045
*K.Arakawa, M.Ikawa, *H.Tada, *H.Okazawa,
+M.Yoneda: The Impact of L-arginine administration in patients with
mitochondrial cardiomyopathy evaluated by 11C-acetate-PET, 5th World Congress
on Targeting Mitochondria, 2014.10, Berlin,Germany
1429046
+M.Yoneda, M.Ikawa, *T.Tsujikawa, *T.Mori,
T.Hamano, Y.Nakamoto, *Y.Kiyono, *H.Okazawa: PET imaging of cerebral oxidative
stress in neurodegenerative disorders, 5th World Congress on Targeting
Mitochondria, 2014.10, Berlin,Germany
1429047
T.Naito, +T.Baba, +N.Mukaida, Y.Nakamoto:
Cytotoxic CD4+ Cells Play a Pivotal Role in Cyclophosphamide-Mediated
Cytotoxicity against Hepatoma without Antigen Priming, The 65th Annual Meeting
of the American Association for the Study of Liver Diseases (AASLD 2014),
2014.11, Boston,Massachusetts
1429048
K.Ofuji, +T.Yoshikawa, +Y.Tada, +M.Shimomura,
Y.Nakamoto, +T.Nakatsura: Identification of a Novel HLA-A2 Restricted
Immunotherapeutic Target Derived from an EGFR Mutated Antigen for the Treatment
of Metastatic Liver Tumors, The 65th Annual Meeting of the American Association
for the Study of Liver Diseases (AASLD 2014), 2014.11, Boston,Massachusetts
1429049
Y.Nakamoto, +T.Yamashita, *K.Hiramatsu,
T.Nemoto, H.Suto, +S.Kaneko: Identification of Hypermethylation and
Non-Synonymous Mutations in Genes Down-Regulated during the Process of
Hepatocarcinogenesis in a Model of Chronic Hepatitis B, The 65th Annual Meeting
of the American Association for the Study of Liver Diseases (AASLD 2014),
2014.11, Boston,Massachusetts
1429050
*H.Matsuda, T.Naito, T.Nosaka, T.Nemoto,
M.Ohtani, *K.Hiramatsu, H.Suto, Y.Nakamoto: Serial Changes of
Cellular,Humoral,and Innate Immune Responses following Immunosuppressive
Chemotherapies Responsible for Hepatitis B Virus Reactivation, The 65th Annual
Meeting of the American Association for the Study of Liver Diseases (AASLD
2014), 2014.11, Boston,Massachusetts
1429051
*M.Kubota, O.Yamamura, T.Kamisawa, *C.Igarashi,
*Y.Watabe, *S.Shimada, *T.Tsujikawa, *H.Okazawa, +R.Kato, +H.Yokoi, *K.Uchida,
*H.Baba: Cortical patterns and functional recovery in chronic stroke patients
by functional electrical stimulation, American Society for Neurorehabilitation
Annual Meeting 2014, 2014.11, Washington DC (USA)
1429052
O.Yamamura,
*T.Kamisawa, T.Hamano, Y.Nakamoto, *M.Kubota, *C.Igarashi, *Y.Watabe,
*S.Shimada, *H.Okazawa, +R.Kato, +H.Yokoi, *k.Uchida, *H.Baba: Effect of burst
stimulation by high frequency biphasic square-wave pulse on cortical perfusion
after stroke: A pilot study, American Society for Neurorehabilitation Annual
Meeting 2014, 2014.11, Washington DC (USA)
1429053
+K.Miyazaki, M.Ikawa, *T.Tsujikawa, *T.Mori,
T.Hamano, Y.Nakamoto, *Y.Kiyono, *H.Okazawa, +M.Yoneda: Increased cerebral
oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study, The
11th Conference of Asian Society for Mitochondrial Research and Medicine,
2014.11, Taipei,Taiwan
1429054
T.Nemoto, *H.Matsuda, T.Nosaka, Y.Saito,
Y.Ozaki, T.Naito, K.Takahashi, K.Ofuji, M.Ohtani, *K.Hiramatsu, H.Suto,
Y.Nakamoto: Comparison of interferon-alpha combined with hepatic arterial
infusion chemotherapy and sorafenib in patients with advanced hepatocellular
carcinoma, 2015 Keystone Symposia Conference@Tumor
Immunology:Multidisciplinary Science Driving Combination Therapy, 2015.02,
Banff,Alberta,Canada
(2) ‘“àŠw‰ïi‘S‘ƒŒƒxƒ‹j
aDµ‘ÒE“Á•Êu‰‰“™
1429055
ûM–ì@’‰‘¥: ŽáŽèˆãŽt‚Ì‚½‚ß‚ÌuŠ´õ‚ƖƉuvƒZƒ~ƒi[
uƒEƒCƒ‹ƒX«‘–Œ‰ŠE”]‰Š‚Ìf’f‚ÆŽ¡—Ãv, ‘æ19‰ñ“ú–{_ŒoŠ´õÇŠw‰ï‘‰ïŠwpW‰ïE‘æ26‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï
‡“¯ŠwpW‰ï, 2014.09, ‹à‘ò
1429056
’†–{@ˆÀ¬: Ķˆã—Ó™ˆÀ‘S«Šm•Û–@‚ɑ΂·‚é“–‰@‚Å‚ÌŽæ‚è‘g‚Ý, ‘æ14‰ñ“ú–{Ķˆã—Êw‰ï‘‰ï, ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[4 Ķˆã—Ê֘A–@Ž{sŒã‚̃AƒJƒfƒ~ƒAAŠé‹Æ‚»‚ꂼ‚ê‚ÌŽæ‚è‘g‚Ý, 2015.03, ‰¡•l
bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™
1429057
*‹v•Û“c@‰ëŽj, _àV@•üŽq, *ŒÜ\—’@çH, ŽR‘º@C, *“ˆ“c@½ˆê˜Y, *¼”ö@‰p–¾, *¬£@œA—º, *‰ª‘ò@G•F, +‰Á“¡@—´, +‰¡ˆä@_Žj, *“à“c@Œ¤‘¢, *”nê@‹v•q: 1
‚©ŒŽŠÔ‚ÌW’†“I‚È‹@”\“I“d‹CŽhŒƒ—Ö@‘OŒã‚̉^“®‹@”\‚Æ”]‹@”\‰æ‘œ‚̕ω»FÇ—á•ñ, ‘æ49‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï,
2014.05, ‰¡•l
1429058
*•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: ‰ü—ÇŒ^ƒoƒCƒ|[ƒ‰ØŠJ”—£—pƒiƒCƒt(Jet B knife)‚É‚æ‚é‘å’°ESD`Ž¿‚ÌŒüã‚ƃRƒXƒg‚ðˆÓŽ¯‚µ‚Ä`, ‘æ87‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï, ‘å’°ESD‚Ì“K‰ž‚ÆŽè‹Z,
2014.05, •Ÿ‰ª
1429059
{“¡@O”V, +‰Á“¡@‘쎟, ’†–{@ˆÀ¬:
H.pyloriœ‹ÛŒã‚̃fƒBƒXƒyƒvƒVƒAÇóCBMI‚Ì’·ŠúŒo‰ß‚ƈݔS–ŒˆÞk‚Æ‚ÌŠÖ˜A, ‘æ88‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï, HPŒ¤‹†‚ÌVŽž‘ã-•a‘Ô¶—‚©‚看ۂ܂Å-, 2014.10, _ŒË
1429060
ŽR‘º@C, +A“c@Mô, +ŽÄ“c@@ˆê, +‰““¡@ŒO, +âV“¡@², +ˆî—t@‘, +‰|–{@’ˆê: ˜j—E‘Š‘o’nˆæ‚̉¼ÝZ‘î’c’n‚É‚¨‚¯‚é[•”Ö¬ŒŒðÇ, ‘æ17‰ñ@“ú–{ðŽqŒŸo‚ÆŽ¡—Êw‰ï
Embolus2014, Šé‰æƒVƒ“ƒ|ƒWƒEƒ€3@”íÐ’nˆã—Ã, 2014.10, •Ÿ‰ª
1429061
*ªÎ@Šgs, *–kˆä@—²•½, ûM–ì@’‰‘¥, *Žl•û@ŽuV, *ŽR“c@^•ã, *ˆéú±@½, *‹´–{@’qÆ, *—L“‡@‰pF, *¬Ž›@rº, *‹e“c@Œ’ˆê˜Y: “Á”«³íˆ³…“ªÇ‚ƃAƒ‹ƒcƒnƒCƒ}[•a‚ÌMRI‚É‚¨‚¯‚éŠÓ•Ê26Ç—á‚ÌŒŸ“¢, ‘æ73‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï, iNPH ] ƒKƒCƒhƒ‰ƒCƒ“‰ü•Ï‚𓥂܂¦‚Ä, 2014.10, “Œ‹ž
cDˆê”Êu‰‰iŒû‰‰j
(1329104)
•Ä“c½, ˆä쳓¹, +´–ìçŒbŽq, *ì’J³’j, *”¨ˆè], *‘O“c_K, *¬â@_—², *“ŒŠÔ³l, *¼–ØFŸ, *˜a“c—LŽi: •Ÿˆä‘åŠwˆâ“`f—Õ”‚ÌŒ»ó‚Ɖۑè, ‘æ58‰ñ“ú–{l—Þˆâ“`Šw‰ï,
2013.11, ‹{é
1429062
*‰ª‘ò@G•F, ˆäì@³“¹, *’Òì@“N–ç, *•Ä“c@½, *X@“N–ç, *´–ì@‘×: 62Cu-ATSM
PET‚É‚æ‚é‹ØˆÞk«‘¤õd‰»Ç(ALS)‚Ì•]‰¿, ‘æ73‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï,
2014.04, ‰¡•l
1429063
ª–{@•üK, *•½¼@ŠˆŽu, *¼“c@GŠx, ‘å’J@¹O, {“¡@O”V, ’†–{@ˆÀ¬: Ž©ŒÈ–Ɖu«ŠÌ‰Šƒ‚ƒfƒ‹‚É‚¨‚¯‚é“]ŽÊ—}§ˆöŽqId2‚ÌŠÖ—^, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï,
2014.05, “Œ‹ž
1429064
“à“¡@’BŽu, +”nê@’q‹v, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, *•½¼@ŠˆŽu, +Œü“c@’¼Žj, ’†–{@ˆÀ¬: RŠà‰»Šw—Ö@‚É‚¨‚¯‚éCD4—z«×–EŠQ«TƒŠƒ“ƒp‹…‚É‚æ‚鎩‘R–Ɖu”½‰ž‚ÌŒŸ“¢, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï,
2014.05, “Œ‹ž
1429065
*•½¼@ŠˆŽu, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, *”ò“c@ª’j, *–Ø‘º@GŽ÷, +‘]‰Æ@‹`”Ž, ’†–{@ˆÀ¬: CŒ^ŠÌ‰ŠŠ³ŽÒ‚É‚¨‚¯‚éHLA-class‡U—̈æSNPv‘¬‰ðÍ–@‚ÌŠJ”, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï,
2014.05, “Œ‹ž
1429066
‘å“¡@˜a–ç, ’†–{@ˆÀ¬, +’†–Ê@“N–ç: V‹KR‘Ì‚ð—p‚¢‚½ŠÌ‚ª‚ñŒŒ‰tƒ}[ƒJ[‚Æ‚µ‚Ä‚Ì
Glypican-3 ŒŸoŒn‚ÌŠJ”, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï,
2014.05, “Œ‹ž
1429067
ûM–ì@’‰‘¥, ”’“¡@–@“¹,
+Shu-Hui Yen, —Ñ@_Žk, ¼‰i@»Žq, ŽR‘º@C, +“¡“c@—S”V, +ˆÀì@‘P”Ž, +ŒIŽR@Ÿ, ’†–{@ˆÀ¬:
ROCK‘jŠQ–ò‚̃^ƒE’`”’ƒŠƒ“Ž_‰»Ed‡‚É‹y‚Ú‚·‰e‹¿, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï,
2014.05, •Ÿ‰ª
1429068
“à“¡@’BŽu, +”nê@’q‹v, ’†–{@ˆÀ¬, +Œü“c@’¼Žj: ×–EŠQ«CD4+×–E‚̓VƒNƒƒzƒXƒtƒ@ƒ~ƒh‚É‚æ‚éŽîá‡×–EŠQ‚ÉRŒ´”ñˆË‘¶“I‚ÉŠÖ—^‚·‚é, ‘æ73‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï,
2014.09, ‰¡•l
1429069
–kú±@—CŽ÷, ŽRŒû@’q‹v, ŽRŽè@NŽi, _àV@•üŽq, ‰|–{@’ˆê, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, *–Ø‘º@_•F, ûM–ì@’‰‘¥:
Creutzfeldt Jakob•a‚ÌArterial Spin Labeling(ASL)Ÿó—¬‰æ‘œŠŒ©, ‘æ19‰ñ“ú–{_ŒoŠ´õÇŠw‰ï‘‰ïŠwpW‰ï,
2014.09, ‹à‘ò
1429070
*‘O“c@•¶], ª–{@•üK, *ûM“c@•q•F, *‹´–{@‹Vˆê, *‘å’|@—R, *’Óc@—T”üŽq, *Šâ–ì@³”V, *–Ø‘º@GŽ÷, ’†–{@ˆÀ¬: —pŽè“I‰Áˆ³–@‚É‚æ‚éƒGƒ‰ƒXƒgƒOƒ‰ƒtƒB‚ð—p‚¢‚½ƒEƒCƒ‹ƒX«–«ŠÌ‰Š‚É‚¨‚¯‚éŠÌüˆÛ‰»•]‰¿–@‚ÌŒŸ“¢, ‘æ61‰ñ“ú–{—Õ°ŒŸ¸ˆãŠw‰ïŠwpW‰ï, —Õ°ŒŸ¸‚ð‰ÈŠw‚·‚é, 2014.11, •Ÿ‰ª
1429071
+²X–Ø@”ü“ÞŽq, ŽR‘º@C, *›’J@ˆŸ¶, *•“c@—L‹IŽq, *”’“¡@–@“¹, *’†‘º@•q–¾, *‰|–{@’ˆê, +’JŒû@–œ’qŽq, +Îã@WŽO: ƒT[ƒrƒX•t‚—îŽÒŒü‚¯Z‘î‹ZŽÒ‚ð‘ÎÛ‚Æ‚µ‚½“d‹CŽg—p—Ê‚Æ…“¹Žg—p—ʂ̉ðÍ‚ÉŠî‚‚—îŽÒ‹}•Ï—\‘ª‚ÌŒ¤‹†, ‘æ19‰ñ@“ú–{Ý‘îƒPƒAŠw‰ï@Šwp‘å‰ï,
2014.11, •Ÿ‰ª
1429072
*’r“c@˜a”ü, ”’“¡@–@“¹, ‘º¼@—ÏŽq, _àV@•üŽq, ã–ì@ˆŸ²Žq, ¼‰i@»Žq, ŽR‘º@C, *¡‘º@DÍ, ûM–ì@’‰‘¥:
Lambert]Eaton‹Ø–³—ÍÇŒóŒQ‚ð‡•¹‚µ‚½_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á, ‘æ32‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï,
2014.11, “Œ‹ž
1429073
ŽRŒû@’q‹v, ¼‰i@»Žq, ”’“¡@–@“¹, ‰|–{@’ˆê, ŽRŽè@NŽi, ‘º¼@—ÏŽq, _àV@•üŽq, ŽR‘º@C, ûM–ì@’‰‘¥, *àVˆä@—˜ŽŸ:
IVIg—Ö@‚ª‘tŒø‚µ‚½ƒXƒeƒƒCƒh’ïR«‚Å‚ ‚Á‚½–TŽîᇫ‰óŽ€«ƒ~ƒIƒpƒ`[‚Ì1 —á, ‘æ32‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï,
2014.11, “Œ‹ž
1429074
ŽR‘º@C:
DVTŒŸf‚©‚ç‚Ý‚½‰¼ÝZ‘î’c’n‚É‚¨‚¯‚鶊ˆKŠµ•a‚̕ω», ‘æ20‰ñ@“ú–{W’cЊQˆãŠw‰ï‘‰ïEŠwpW‰ï,
2014.12, “Œ‹ž
1429075
ŽR‘º@C: ’Ôg”íÐ’n‚Æ”]‘²’†ŠëŒ¯ˆöŽq@`˜j—ŒSŒ¤‹†`, ‘æ40‰ñ@“ú–{”]‘²’†Šw‰ï‘‰ï,
2015.03, L“‡
1429076
ŽR‘º@C, *_àV@•üŽq, *‹v•Û“c@‰ëŽj, *ŒÜ\—’@çH, à_–ì@’‰‘¥, +‰Á“¡@—´, +‰¡ˆä@_Žj, *‰ª‘ò@G•F: V‚½‚ÈŽü”g”‘Ñ‚ð—p‚¢‚½‹@”\“I“d‹CŽhŒƒ—Ö@‚É‚¨‚¯‚é”]‹@”\‰æ‘œ‚̕ω», ‘æ40‰ñ@“ú–{”]‘²’†Šw‰ï‘‰ï,
2015.03, L“‡
1429077
*ªÎ@Šgs, *–kˆä@—²•½, ûM–ì@’‰‘¥, *Žl•û@ŽuV, *ŽR“c@^•ã, *“Œ–ì@–FŽj, *ˆéú±@½, *‹´–{@’qÆ, *—L“‡@‰pF, *‹e“c@Œ’ˆê˜Y: “Á”«³íˆ³…“ªÇ‚Æ”]ŒŒŠÇ«”F’mÇ‚Æ‚ÌMRI‚É‚æ‚éŠÓ•Ê28Ç—á‚Ì”äŠrŒŸ“¢, ‘æ40‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï,
2015.03, L“‡
dDˆê”Êu‰‰iƒ|ƒXƒ^[j
1429078
*–ìã@‘ñl, *•½¼@ŠˆŽu, ’†–{@ˆÀ¬: ŠJ• Žèp—ð‚Ì‚ ‚éÇ—á‚É‚¨‚¯‚éPatency
capsule‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢, ‘æ100‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï,
2014.04, “Œ‹ž
1429079
”’“¡@–@“¹, ûM–ì@’‰‘¥, *Γc@ˆ¤Žq, ¼‰i@»Žq, ã–ì@ˆŸ²Žq, —Ñ@_Žk, ŽR‘º@C, +ŒIŽR@Ÿ, ’†–{@ˆÀ¬: ƒAƒ‹ƒcƒnƒCƒ}[•a‚ƃzƒ‚ƒVƒXƒeƒCƒ“, ‘æ111‰ñ“ú–{“à‰ÈŠw‰ï‘‰ïEu‰‰‰ï,
2014.04, “Œ‹ž
1429080
*•“c@—L‹IŽq, ŽR‘º@C, *‰|–{@’ˆê, *”’âÙ@–@“¹, *’†‘º@•q–¾, ûM–ì@’‰‘¥, *—Ñ@Š°”V, *Ž›àV@Gˆê: ƒT[ƒrƒX•t‚«‚—îŽÒZ‘î‚Ì¢‘Ñ•Ê’²¸‚©‚ç‚Ý‚½ˆã—ØAŒg‚Æ•ž–òŠÇ—‚Ì–â‘è, ‘æ5‰ñ“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ïŠwp‘å‰ï,
2014.05, ‰ªŽR
1429081
*¼“c@GŠx, ª–{@•üK, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚éBŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚ÌŒ»ó‚ƖƉu—}§E‰»Šw—Ö@Ž{sŽž‚̃TƒCƒgƒJƒCƒ““®‘Ԃ̉ðÍ, ‘æ50‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï,
2014.05, “Œ‹ž
1429082
*ŒÜ\—’@çH, *‹v•Û“c@‰ëŽj, +_àV@•üŽq, ŽR‘º@C, *‰ª‘ò@G•F, +‰Á“¡@—´, +‰¡ˆä@_Žj, *“ˆ“c@½ˆê˜Y, +”nê@‹v•q: ”]‘²’†Š³ŽÒ‚ɑ΂·‚é“d‹CŽhŒƒ‚𕹗p‚µ‚½‰ºŽˆL“W‰^“®‰Û‘肪”]Šˆ“®‚É—^‚¦‚é‰e‹¿, ‘æ49‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï,
2014.05, ‰¡•l
1429083
‚‹´@˜al, {“¡@O”V, ÔàV@—I, ꎓ¡@‹±Žu, “c’†@’mŽq, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, ’†–{@ˆÀ¬: ‚—îŽÒ‚É‚¨‚¯‚éˆÝESDŽ¡—ìт̌Ÿ“¢, ‘æ87‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï,
2014.05, •Ÿ‰ª
1429084
‰““¡@–F“¿, —Ñ@_Žk, +ŽRè@–@–¾, +‚”©@–õŽu, +Œüˆä@—TC, +Žá¼@Oˆê, +‰F–ì@‰pˆê:
rt-PAÃ’—Ö@‚ðŽ{s‚µ‚½”][ÇÇ—á‚ÉŠÖ‚·‚錟“¢, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï,
2014.05, •Ÿ‰ª
1429085
—Ñ@_Žk, ‰““¡@–F“¿, ¼‰i@»Žq, ŽR‘º@C, +ŒIŽR@Ÿ, ûM–ì@’‰‘¥: ‹Ø‹’¼«ƒWƒXƒgƒƒtƒB[1Œ^Š³ŽÒ‚Ì㎈‹ØMRIŠŒ©‚Ì“Á’¥, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï,
2014.05, •Ÿ‰ª
1429086
”’“¡@–@“¹, ûM–ì@’‰‘¥, *Γc@ˆ¤Žq,
+Shu-Hui Yen, ¼‰i@»Žq, ŽR‘º@C, +ŒIŽR@Ÿ: ƒzƒ‚ƒVƒXƒeƒCƒ“‚É‚æ‚éƒ^ƒE’`”’ƒŠƒ“Ž_‰»Ed‡‘£i‹@˜‚̉ð–¾, ‘æ55‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï,
2014.05, •Ÿ‰ª
1429087
+A“c@Mô, +楱‘ò@˜a•F, ŽR‘º@C, +²X–Ø@ˆê—T: ‘å‹K–ÍЊQ‚É‚¨‚¯‚é”][ǂ̃ŠƒXƒNˆöŽq‚Æ‚µ‚ẲºŽˆ[•”Ö¬ŒŒðÇ, ‘æ33‰ñ@“ú–{”]_Œo’´‰¹”gŠw‰ï‘‰ï,
2014.06, ŠâŽè
1429088
*‘O“c@_K, *’†àV@‰ëŽq, *“c’†@–ƒ“Þ”ü, *“Œ@•ä, *¬—û@Œ¤Ži, *ŒÜˆä@FŒ›, *•ÐŽR@Š°ŽŸ, *¡‘º@DÍ, •Ä“c@½, *ŽRŒû@–¾•v: ‰Æ‘°«“ûŠà‚Ì—Õ°•a—Šw“IŒŸ“¢, ‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï,
2014.07, ‘åã
1429089
‘å“¡@˜a–ç, +‹gì@‘–¾, +‘½“c@DF, +‹g‘º@–ƒ—FŽq, +‰º‘º@^Ø”ü, ’†–{@ˆÀ¬, +’†–Ê@“N–ç: ”ñ¬×–E”x‚ª‚ñ‚É‚¨‚¯‚éEGFR
T790M •ÏˆÙ—R—ˆRŒ´‚͖ƉuŒ´«‚ð—^‚¦‚é, ‘æ73‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï,
2014.09, ‰¡•l
1429090
ꎓ¡@‹±Žu, {“¡@O”V, ”öú±@‰Ã•F, ‚‹´@˜al, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, ’†–{@ˆÀ¬:
ESDŒã’×ᇎ¡–ü‚ð‘J‰„‚³‚¹‚éˆöŽq‚ɂ‚¢‚Ä‚ÌŒŸ“¢, ‘æ88‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï,
2014.10, _ŒË
1429091
à_–{@ˆ¤Žq, ª–{@•üK, ”öú±@‰Ã•F, “à“¡@’BŽu, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚é”ñB”ñCŒ^ŠÌ×–EŠà‚Ì—Õ°“I“Á’¥‚ÌŒŸ“¢, ‘æ18‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï,
2014.10, _ŒË
1429092
“c’†@’mŽq, *•½¼@ŠˆŽu, ‘å“¡@˜a–ç, ‚‹´@˜al, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚éƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ““àŽ‹‹¾‚É‚æ‚鬒°ŒŸ¸‚ÌŒ»ó, ‘æ56‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï,
2014.10, _ŒË
1429093
—L’Ë@“ÖŽj, ‘å’J@¹O, ‚‹´@˜al, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚ÌIPMNŽèpÇ—á‚É‚¨‚¯‚éäX‰t×–EfEäX‰t’†CEA’l‚ÌŒŸ“¢, ‘æ56‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï,
2014.10, _ŒË
1429094
ª–{@•üK, *‘O“c@•¶], *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, *ûM“c@•q•F, *–Ø‘º@GŽ÷, *Šâ–ì@³”V, ’†–{@ˆÀ¬: ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ÌüˆÛ‰»•]‰¿‚É‚¨‚¯‚é’´‰¹”gƒGƒ‰ƒXƒgƒOƒ‰ƒtƒB‚Ì—L—p«‚ÌŒŸ“¢, ‘æ18‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï,
2014.10, _ŒË
1429095
–ìã@‘ñl, *¼“c@GŠx, ”öú±@‰Ã•F, “à“¡@’BŽu, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ƒXƒeƒƒCƒh“à•ž—Ö@‚É‚¨‚¯‚éBŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚ÌŒ»ó, ‘æ18‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï,
2014.10, _ŒË
1429096
‚‹´@˜al, {“¡@O”V, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, ’†–{@ˆÀ¬: ˆÝESDÇ—á‚É‚¨‚¯‚錌´RƒwƒŠƒRƒoƒNƒ^[EƒsƒƒŠIgGR‘Ì‚ÉŠÖ‚·‚錟“¢, ‘æ56‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï,
2014.10, _ŒË
1429097
*ì’J@³’j, ˆäì@³“¹, +´–ì@’qŒbŽq, *‘O“c@_K, •Ä“c@½, *”¨@ˆè]:
MLPA–@‚ŃWƒXƒgƒƒtƒBƒ“ˆâ“`Žq‚Ì‹U—z«‚ð’悵‚½1—á, ‘æ59‰ñ“ú–{l—Þˆâ“`Šw‰ï,
2014.11, ]ŒËì‹æ
1429098
—Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: ”Ç4.5ŽžŠÔˆÈ“à‚ÉMRI-CASL‰æ‘œ‚ðŽB‰e‚µ‚½rt-PAÇ—á‚ÌŒŸ“¢, ‘æ40‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï,
2015.03, L“‡
eD‚»‚Ì‘¼
1429099
ŽR‘º@C: ˆê”ÊŒû‰‰8@uƒRƒtƒH[ƒgEIMTE[•”Ö¬ŒŒðv@À’·, ‘æ33‰ñ@“ú–{”]_Œo’´‰¹”gŠw‰ï‘‰ï,
2014.06, ŠâŽè
(3) ‘“àŠw‰ïi’nˆæƒŒƒxƒ‹j
aDµ‘ÒE“Á•Êu‰‰“™
1429100
ŽR‘º@C: ЊQŒ»ê‚©‚ç‚Ý‚¦‚½î•ñ‹¤—L‚ƃPƒAƒ}ƒlƒWƒƒ[‚Ì–ðŠ„, •½¬26”N“xiŽÐj•ŸˆäŒ§‰îŒìŽx‰‡ê–åˆõ‹¦‰ï@‘æ5‰ñŠwp‘å‰ï,
2014.11, •Ÿˆä
1429101
‘å’J@¹O: EUS-FNA‚̃Rƒc‚Ɖž—p, ‘æ23‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤ƒZƒ~ƒi[,
2015.01, •xŽR
bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™
1429102
‘å’J@¹O, —L’Ë@“ÖŽj, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ƒJƒvƒZƒ‹“àŽ‹‹¾ŒŸ¸‚É‚¨‚¯‚éƒpƒeƒ“ƒV[ƒJƒvƒZƒ‹‚Ì—L—p«‚ÌŒŸ“¢, ‘æ103‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï, –k—¤‚É‚¨‚¯‚éƒJƒvƒZƒ‹“àŽ‹‹¾‚ÌŒ»‹µ,
2014.06, •Ÿˆä
cDˆê”Êu‰‰iŒû‰‰j
(1329105)
”’“¡@–@“¹, ¼‰i@»Žq, *¼–{@ˆ², *Œüˆä@–G, *ìú±@Œö”üŒb, *“yŽR@ŽŽ÷, ŽR‘º@C, ûM–ì@’‰‘¥: ‘Šú‚æ‚è”r”AáŠQ‚ª‚Ý‚ç‚ꂽ–³‹Û«‘–Œ‰Š‚Ì1—á, ‘æ222‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï,
2014.03, •Ÿˆä
1429103
ÔàV@—I, *¼“c@GŠx, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ”dŽí«ŒŒŠÇ“à‹ÃŒÅ‚ð‡•¹‚µ‚½‹‘労õ«ŠÌ”X–E‚Ì1—á, ‘æ223‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï,
2014.06, ‹à‘ò
1429104
*ìK@’qŽm, ‘å’J@¹O, ÔàV@—I, —L’Ë@“ÖŽj, “c’†@’mŽq, –ìã@‘ñl, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬:
TAE‚ª—LŒø‚Å‚ ‚Á‚½’¼’°GISTŠÌ“]ˆÚ”j—ô‚Ì1—á, ‘æ118‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï,
2014.06, •Ÿˆä
1429105
*’|ì@—S–¢, *•½¼@ŠˆŽu, ÔàV@—I, “c’†@’mŽq, —L’Ë@“ÖŽj, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬, *‘º‰ª@‹Iº, *´…@@ˆê_, *–Ø‘º@_•F: ‘½”«ŠÌt”X–Eǂɑ΂µ‚ÄŠÌ“®–¬Çðp‚ª—LŒø‚Å‚ ‚Á‚½1—á, ‘æ118‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï,
2014.06, •Ÿˆä
1429106
*’|“à@•¶, ‘å’J@¹O, ÔàV@—I, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ªŽ¡“IŠÌ×–EŠà‹ÇŠŽ¡—ÃŒã‚ɔǂµ‚½ŒÇ—§«cŠuƒŠƒ“ƒpß“]ˆÚ‚Ìf’f‚ÉEUS-FNA‚ª—L—p‚Å‚ ‚Á‚½1—á, ‘æ103‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï,
2014.06, •Ÿˆä
1429107
ŽRŒû@’q‹v, ¼‰i@»Žq, ”’“¡@–@“¹, ‰|–{@’ˆê, ŽRŽè@NŽi, ‘º¼@—ÏŽq, _àV@•üŽq, ŽR‘º@C, ûM–ì@’‰‘¥, *àVˆä@—˜ŽŸ:
IVIg—Ö@‚ª‘tŒ÷‚µ‚½ƒXƒeƒƒCƒh’ïR«‚Å‚ ‚Á‚½–TŽîᇫ‰óŽ€«ƒ~ƒIƒpƒ`[‚Ì1—á, ‘æ139‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï,
2014.07, –¼ŒÃ‰®
1429108
*‘Š–Ø@Fˆò, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, *¡‘º@DÍ, ûM–ì@’‰‘¥:
Lambert-Eaton‹Ø–³—ÍÇŒóŒQ‚ð‡•¹‚µ‚½_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á, ‘æ139‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï,
2014.07, –¼ŒÃ‰®
1429109
ŽRŒû@’q‹v, ‰““¡@–F“¿, –kú±@—CŽ÷, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: ’˜–¼‚È‹N—§«’ጌˆ³‚ð’悵‚½2—á-ƒhƒpƒ~ƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ƒCƒ[ƒWƒ“ƒO‚É‚æ‚錟“¢-, ‘æ224‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï,
2014.09, •xŽR
1429110
ŽRŒû@’q‹v, —Ñ@_Žk, –kú±@—CŽ÷, ‰““¡@–F“¿, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, ŽR‘º@C, ûM–ì@’‰‘¥, ’†–{@ˆÀ¬: ”xŠàp‘O¸¸Žž‚É”Œ©‚³‚ꂽ–³ÇŒó«”][Ç‚Ì1—á, ‘æ25‰ñ“ú–{˜V”NˆãŠw‰ï–k—¤’n•û‰ï,
2014.10, ‹à‘ò
1429111
*‘Oì@“WœA, ‰““¡@–F“¿, –kú±@—CŽ÷, ŽRŒû@’q‹v, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, +¬’r@tŽ÷, +‰i“c@”ü˜aŽq, ûM–ì@’‰‘¥: _Œo¶ŒŸ‚Åf’f‚µ‚¦‚½‰Æ‘°«ƒAƒ~ƒƒCƒhƒ|ƒŠƒjƒ…[ƒƒpƒ`[(FAP)‚Ì1—á, ‘æ140‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï,
2014.11, •Ÿˆä
1429112
*Š|‹´@¸‘¾, ‘å’J@¹O, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ƒjƒRƒ‰ƒ“ƒWƒ‹‹x–ò‚ª—LŒø‚Å‚ ‚Á‚½“«oŒŒ«¬’°’×ᇂÌ1—á, ‘æ104‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï,
2014.11, Îì
1429113
*—L‰ê@÷, *•½¼@ŠˆŽu, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: Žá”N’j«‚ɔǂµ‚½“Á”«’°ŠÇ”X–Eó‹CŽîǂ̈ê—á, ‘æ104‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï–k—¤Žx•”—á‰ï,
2014.11, Îì
1429114
*‘Oì@“WœA, *¼“c@GŠx, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, –ìã@‘ñl, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, *¬—û@Œ¤Ži, *ŽRŒû@–¾•v, ’†–{@ˆÀ¬: ŠÌ“®’‰»Šw—Ö@‚ÆŠÌ“®–¬‰»ŠwÇð—Ö@Ž{sŒã‚ÉØœ‚µ‚½’_ŠÇ“à”ˆçŒ^ŠÌ×–EŠà‚Ì1—á, ‘æ119‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï,
2014.11, ‹à‘ò
1429115
*a’J@‰Ã¬, ª–{@•üK, –ìã@‘ñl, —L’Ë@“ÖŽj, ꎓ¡@‹±Žu, “c’†@’mŽq, ”öú±@‰Ã•F, ‚‹´@˜al, “à“¡@’BŽu, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: ƒgƒ‹ƒoƒvƒ^ƒ“‚ª—LŒø‚Å‚ ‚Á‚½CŒ^ŠÌd•Ï‚ɇ•¹‚µ‚½‘å—Ê“û‚Ñ• …‚Ì1—á, ‘æ119‰ñ“ú–{Á‰»Ší•aŠw‰ï–k—¤Žx•”—á‰ï,
2014.11, ‹à‘ò
1429116
”’“¡@–@“¹, ˆäì@³“¹, ‰““¡@–F“¿, ŠÝ’J@—Z, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥, +¼‘º@—mº, +—é–Ø@d–¾: RHMGCRR‘Ì—z«‰óŽ€«‹Ø‰Š‚Ì1—á, ‘æ141‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï,
2015.03, –¼ŒÃ‰®
1429117
–kú±@—CŽ÷, ŽRŒû@’q‹v, ‰““¡@–F“¿, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: áz¹”ì‚ŔǂµASL‰æ‘œ‚ªf’f‚É—L—p‚Å‚ ‚Á‚½d–Œ“®Ã–¬á‘‚Ì1—á, ‘æ141‰ñ“ú–{_ŒoŠw‰ï“ŒŠC–k—¤’n•û‰ï,
2015.03, –¼ŒÃ‰®
1429118
*‰F“s‹{@Œd, *¼“c@GŠx, ”öú±@‰Ã•F, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, {“¡@O”V, *“c‹@Ž‹K, *ã“c@F“T, ’†–{@ˆÀ¬: •ÂÇ«‰©át‚ŔǂµC’´‰¹”gƒKƒCƒh‰ºŽîᇶŒŸ‚É‚æ‚èf’f‚µ“¾‚½ˆ««ƒŠƒ“ƒpŽî‚Ì1—á, ‘æ225‰ñ“ú–{“à‰ÈŠw‰ï–k—¤’n•û‰ï,
2015.03, ‹à‘ò
(4) ‚»‚Ì‘¼‚ÌŒ¤‹†‰ïEW‰ï
aDµ‘ÒE“Á•Êu‰‰“™
1429119
’†–{@ˆÀ¬: BŒ^ŠÌ‰Š‚Æ”‚ª‚ñ‚Ì•a‘ÔŠw, ‘æ9‰ñŽl‘ŠÌŽ¾Š³Œ¤‹†‰ï,
2014.06, ¼ŽR
1429120
’†–{@ˆÀ¬: –«ŠÌ‰Š‚©‚甂ª‚ñ‚ւ̖Ɖu•a‘ÔŠw, ‘æ6‰ñ•Ÿ“‡Œ§Ž©ŒÈ–Ɖu«ŠÌŽ¾Š³Œ¤‹†‰ï,
2014.11, •Ÿ“‡
1429121
’†–{@ˆÀ¬: ŠÌ‚ª‚ñ‚Ì•a‘Ô‚ÆV‚½‚ÈŽ¡—Ãí—ª, ‘æ15‰ñ‰ªŽRŠÌŽ¾Š³Œ¤‹†‰ï,
2015.03, ‰ªŽR
bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™
1429122
’†–{@ˆÀ¬: Treatment of HBV-infected Patients
in Japan, 2014 International Symposium on Viral Hepatitis in Asia, 2014.12,
Hanoi,Vietnam
cDˆê”Êu‰‰iŒû‰‰j
1429123
*•½¼@ŠˆŽu, *¼“c@GŠx, ª–{@•üK, ’†–{@ˆÀ¬: CŒ^ŠÌ‰ŠŠ³ŽÒ‚É‚¨‚¯‚éHLAƒNƒ‰ƒX‡U—̈æSNP‚ÌŒŸ“¢, ‘æ24‰ñRƒEƒCƒ‹ƒX—Ö@Œ¤‹†‰ï‘‰ï,
2014.05, ŽR—œ
1429124
*ªÎ@Šgs, *Žl•û@ŽuV, *ŽR“c@^•ã, *ÔàV@ˆ¤‹|, *“Œ–ì@–FŽj, *ˆéú±@½, *‹´–{@’qÆ, *—L“‡@‰pF, *¬Ž›@rº, *–kˆä@—²•½, ûM–ì@’‰‘¥, *‹e“c@Œ’ˆê˜Y: •àsáŠQ‚ªæs‚µ‚½”F’mǂ̈ê—á, ‘æ212‰ñ•Ÿˆä”]_ŒoŽ¾Š³’k˜b‰ï,
2014.05, •Ÿˆä
1429125
‰““¡@–F“¿, *‘O“c@–²‹g, *‘Oì@“WœA, –kú±@—CŽ÷, ŽRŒû@’q‹v, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥: ’˜–¼‚È‹N—§«’ጌˆ³‚ð’悵‚½2Ç—á-ƒhƒpƒ~ƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ƒCƒ[ƒWƒ“ƒO‚É‚æ‚錟“¢-, ‘æ13‰ñ–k—¤ƒp[ƒLƒ“ƒ\ƒ“•aŒ¤‹†‰ï,
2014.06, ‹à‘ò
1429126
ŽRŒû@’q‹v, –kú±@—CŽ÷, ‰““¡@–F“¿, ŠÝ’J@—Z, ”’“¡@–@“¹, ¼‰i@»Žq, —Ñ@_Žk, ŽR‘º@C, ûM–ì@’‰‘¥, ’†–{@ˆÀ¬: Ä”‚ðŒJ‚è•Ô‚µ‚½SŒ´«”]ÇðÇ‚Ì1—á, ‘æ514‰ñ•ŸˆäŒ§“à‰È—Õ°§˜b‰ï,
2014.09, •Ÿˆä
1429127
“à“¡@’BŽu, +Œü“c@’¼Žj, ’†–{@ˆÀ¬: ŠÌŠà‰»Šw—Ö@‚ÌRŽîᇌø‰Ê‚É‚¨‚¯‚éCD4(+)CTL‚ÌŠÖ—^, ‘æ25‰ñThe
Meeting of Liver and Immunology, 2014.09, ‹ž“s
1429128
ª–{@•üK: ŠÌ«”]LJ•¹ŠÌd•ÏŠ³ŽÒ‚ɑ΂·‚éƒJƒ‹ƒjƒ`ƒ“‚Ì—L—p«‚ÌŒŸ“¢, ‘æ4‰ñ•ŸˆäŠÌ‘Ÿ‰h—{ƒtƒH[ƒ‰ƒ€,
2014.09, •Ÿˆä
1429129
”öú±@‰Ã•F, {“¡@O”V, –ìã@‘ñl, ꎓ¡@‹±Žu, “à“¡@’BŽu, ‚‹´@˜al, ‘å“¡@˜a–ç, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, ª–{@•üK, *¡‘º@DÍ, ’†–{@ˆÀ¬:
ESD‚ÅŽ¡–ü‚µ‚¦‚½30Αä‚ɔǂµ‚½Helicobacter
pylori‰A«’°Œ^•ª‰»Œ^ˆÝŠà‚Ì1—á, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`,
2014.09, •Ÿˆä
1429130
‘å“¡@˜a–ç, +‹gì@‘–¾, +‘½“c DF, +‹g‘º –ƒ—FŽq, +‰º‘º ^Ø”ü, ’†–{@ˆÀ¬, +’†–Ê “N–ç: “]ˆÚ«ŠÌŽîᇂɑ΂·‚éV‹KHLA-A2S‘©«EGFR•ÏˆÙ—R—ˆ•W“IRŒ´‚Ì“¯’è, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`,
2014.09, •Ÿˆä
1429131
*¼“c@GŠx, “à“¡@’BŽu, –ìã@‘ñl, ª–{@•üK, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: BŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚̃ŠƒXƒN‚ð—L‚·‚é–Ɖu—}§E‰»Šw—Ö@‚É‚¨‚¯‚éAŒŒ´ƒTƒCƒgƒJƒCƒ““®‘Ԃ̉ðÍ, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`, 2014.09,
•Ÿˆä
1429132
*•½¼@ŠˆŽu, *¼“c@GŠx, ‘å’J@¹O, ª–{@•üK, {“¡@O”V, ’†–{@ˆÀ¬: ‘å’°ESD‚É‚¨‚¯‚éV‹KƒoƒCƒ|[ƒ‰Œ^ØŠJ”—£ƒfƒoƒCƒXAƒWƒFƒbƒgB-ƒiƒCƒt‚Ì—L—p«‚ÌŒŸ“¢, ‘æ7‰ñ…å‚̉ï`‘æ18‰ñÁ‰»ŠíŠwpƒZƒ~ƒi[`,
2014.09, •Ÿˆä
1429133
*ˆéú±@½, *—L“‡@‰pF, *ªÎ@Šgs, *Žl•û@ŽuV, *ŽR“c@^•ã, *“Œ–ì@–FŽj, *‹´–{@’qÆ, *¬Ž›@rº, *–kˆä@—²•½, ŠÝ’J@—Z, ûM–ì@’‰‘¥, *–Ø‘º@_•F, *‹e“c@Œ’ˆê˜Y: ŠC–ÈÖ¬“´•”d–Œ“®Ã–¬á‘(CSdAVF)‚É‚¨‚¯‚éASL•]‰¿, ‘æ29‰ñ•ŸˆäŒ§”]‹@”\‰æ‘œƒJƒ“ƒtƒ@ƒŒƒ“ƒX,
2014.10, •Ÿˆä
1429134
{“¡@O”V: H.pyloriœ‹ÛŒã‚̃fƒBƒXƒyƒvƒVƒAÇóABMI‚Ì’·ŠúŒo‰ß, ‘æ1‰ñ•ŸˆäÁ‰»Ší•aƒtƒH[ƒ‰ƒ€,
2014.12, •Ÿˆä
1429135
ŽRŒû@’q‹v, —Ñ@_Žk, ûM–ì@’‰‘¥: ¶–[”S‰tŽîC¶SŽ¨“àŒŒð‚ªŒ´ˆö‚Æl‚¦‚ç‚ꂽSŒ´«”]ÇðÇ‚Ì1—á, ‘æ216‰ñ•Ÿˆä”]E_ŒoŽ¾Š³’k˜b‰ï,
2015.01, •Ÿˆä
1429136
–kú±@—CŽ÷, ŽRŒû@’q‹v, ‰““¡@–F“¿, ŽRŽè@NŽi, _àV@•üŽq, ŠÝ’J@—Z, ”’“¡@–@“¹, ‰|–{@’ˆê, ¼‰i@»Žq, —Ñ@_Žk, *–Ø‘º@_•F, ŽR‘º@C, ûM–ì@’‰‘¥: ŒÇ”«Creutzfeldt-Jakob•a‚ÌASLŸó—¬‰æ‘œŠŒ©, ‘æ30‰ñ•ŸˆäŒ§”]‹@”\‰æ‘œƒJƒ“ƒtƒ@ƒŒƒ“ƒX,
2015.03, •Ÿˆä
dDˆê”Êu‰‰iƒ|ƒXƒ^[j
1429137
”öú±@‰Ã•F, ª–{@•üK, *¼“c@GŠx, ‘å’J@¹O, *•½¼@ŠˆŽu, {“¡@O”V, ’†–{@ˆÀ¬: “–‰@‚É‚¨‚¯‚é”ñƒAƒ‹ƒR[ƒ‹«Ž‰–b«ŠÌ‰Š(NASH)‚ð”wŒi‚Æ‚µ‚½ŠÌ×–EŠà‚Ì—Õ°•a—Šw“I“Á’¥‚ÌŒŸ“¢, ‘æ50‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï,
2014.06, ‹ž“s
‹æ•ª |
Œ¤‹†Ží–Ú |
‰Û@‘è@–¼ |
‘ã•\ŽÒ–¼ |
•ª’SŽÒ–¼ |
Šú@ŠÔ i”N“xj |
‹à@Šz i”z•ªŠzj |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
Šî”ÕŒ¤‹†(B)iˆê”Êj |
ŠÌ‘Ÿ‚Ì–«‰ŠÇ‚ª—U“±‚·‚锂ª‚ñŒó•âˆâ“`Žq‚É‚¨‚¯‚éƒhƒ‰ƒCƒo[•ÏˆÙ‚Ì“¯’è |
’†–{@ˆÀ¬ |
|
2014 |
5,850ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
’§í“I–G‰èŒ¤‹† |
ƒ}ƒCƒNƒƒLƒƒƒrƒeƒBƒAƒŒƒC‰t‘̶ŒŸ‹Zp‚ð—p‚¢‚½ŠÌ‚ª‚ñÄ”’´‘Šúf’f–@‚ÌŠJ” |
’†–{@ˆÀ¬ |
|
2014 |
1,430ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
Šî”ÕŒ¤‹†(C)iˆê”Êj |
ƒ^ƒE’`”’ƒIƒŠƒSƒ}[‚ª—U“±‚·‚éƒAƒ‹ƒcƒnƒCƒ}[•a‚Ì•ªŽq‹@˜‚̉ð–¾@—Õ°‚ւ̉ž—p |
à_–ì@’‰‘¥ |
”’“¡@–@“¹ |
2014 |
1,560ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
Šî”ÕŒ¤‹†(C)iˆê”Êj |
ˆÝ”Šà‚ð§Œä‚·‚éH•i‚̃GƒsƒWƒFƒlƒeƒBƒNƒX‹@\‚̉ðÍ |
{“¡@O”V |
’†–{@ˆÀ¬ |
2014 |
1,950ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
’§í“I–G‰èŒ¤‹† |
ŠÌƒGƒlƒ‹ƒM[‘ãŽÓ‚ÉŠÖ—^‚·‚éV‹K“]ŽÊ—}§ˆöŽq‚Ì‹@”\‰ðÍ‚Æ‘ãŽÓŠÖ˜AŠÌŽ¾Š³Ž¡—Âւ̉ž—p |
ª–{@•üK |
|
2014 |
1,300ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
Šî”ÕŒ¤‹†(B)iˆê”Êj |
kЂɂæ‚鉼àZ‘î‹ZŽÒ‚̃‚ƒrƒŠƒeƒB‚ÆŒ’N‚ÉŠÖ‚·‚錤‹† |
+Œ³“c@—ÇF |
ŽR‘º@C |
2014 |
650ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
Šî”ÕŒ¤‹†(C)iˆê”Êj |
’Ôg”íÐ’n‚ðƒtƒB[ƒ‹ƒh‚Æ‚µ‚½‰ºŽˆÃ–¬ƒGƒR[ŠŒ©‚ÆŽ~ŒŒ‹@”\ŒŸ¸‚ÌŒ¤‹† |
ŽR‘º@C |
|
2014 |
1,170ç‰~ |
•¶•”‰ÈŠwȉȊw Œ¤‹†”ï•â•‹à |
ŽáŽèŒ¤‹†(B) |
•Ó‰Œn”]‰ŠŒ^‹´–{”]Ç‚Ì—Õ°‘œ‚Æ•a‘Ô‹@˜‚̉𖾠|
¼‰i@»Žq |
|
2014 |
1,690ç‰~ |
‘–±È–k—¤‘‡’ÊM‹Ç‹£‘ˆ“IŽ‘‹à |
í—ª“Iî•ñ’ÊMŒ¤‹†ŠJ”„i§“x(SCOPE) |
Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†ŠJ” |
ŽR‘º@C |
”’“¡@–@“¹ ‰|–{@’ˆê |
2014 |
6246.682ç‰~ |
‘–±Èî•ñ’ÊM‘Ûí—ª‹Ç‹£‘ˆ“IŽ‘‹à |
í—ª“Iî•ñ’ÊMŒ¤‹†ŠJ”„i§“x(SCOPE) |
“ü—ÍŒ^BMI“d‹CŽhŒƒ‚ð—p‚¢‚½‰^“®‚ÆŠ´Šo‚ÌĶ–@‚ÌŒ¤‹†ŠJ” |
ŠÝ’J@—Z |
|
2014 |
3952ç‰~ |
Œú¶˜J“ȉȊw Œ¤‹†”ï•â•‹à |
BŒ^ŠÌ‰Š‘n–òŽÀ—p‰»“™Œ¤‹†Ž–‹Æ |
HBV
cccDNA‚̧Œä‚Æ”rœ‚ð–ÚŽw‚·V‹K–ƉuŽ¡—Öò‚ÌŠJ” |
+‹àŽq@Žüˆê |
’†–{@ˆÀ¬ |
2014 |
3,500ç‰~ |
Œú¶˜J“ȉȊw Œ¤‹†”ï•â•‹à |
ŠÌ‰Š“™Ž•ž‹Ù‹}‘ÎôŒ¤‹†Ž–‹Æ |
ŽŸ¢‘ãƒV[ƒNƒGƒ“ƒX‹Zp‚ð‹ìŽg‚µ‚½ƒEƒCƒ‹ƒXƒQƒmƒ€‰ðÍ‚É‚æ‚éCŒ^ŠÌ‰Š‚Ì•a‘ԉ𖾂Ɨհ‰ž—p |
+‰|–{@MK |
’†–{@ˆÀ¬ |
2014 |
2,000ç‰~ |
Œú¶˜J“ȉȊw Œ¤‹†”ï•â•‹à |
ŠÌ‰Š“™Ž•ž‹Ù‹}‘ÎôŒ¤‹†Ž–‹Æ |
‚aŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXeR‘Ì—z«–³ÇŒó«ƒLƒƒƒŠƒA‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚錟“¢ |
+‰¡{‰ê@Žû |
’†–{@ˆÀ¬ |
2014 |
1,000ç‰~ |
Œú¶˜J“ȉȊw Œ¤‹†”ï•â•‹à |
“«Ž¾Š³ôŒ¤‹†Ž–‹Æ |
ƒXƒ‚ƒ“‚ÉŠÖ‚·‚é’²¸Œ¤‹† |
+¬’·’J@³–¾ |
ûM–ì@’‰‘¥ |
2014 |
700ç‰~ |
Šw“à‹£‘ˆ“IŽ‘‹à |
‹£‘ˆ“I”z•ªŒo”ïE‹³ˆç |
æiˆã—ÃV[ƒYuƒsƒ^ƒoƒXƒ^ƒ`ƒ“‚̃Aƒ‹ƒcƒnƒCƒ}[•aŽ¡—Âւ̉ž—pv |
à_–ì@’‰‘¥ |
|
2014 |
300ç‰~ |
Šw“à‹£‘ˆ“IŽ‘‹à |
‹£‘ˆ“I”z•ªŒo”ïE‹³ˆç |
•½¬26”N“x@u’ni’mj‚Ì‹’“_®”õŽ–‹Æi‘åŠwCOCŽ–‹Æj |
*’·’Jì@”ü |
ŽR‘º@C |
2014 |
753ç‰~ |
Šw“à‹£‘ˆ“IŽ‘‹à |
‚»‚Ì‘¼ |
‚ƒzƒ‚ƒVƒXƒeƒCƒ“ŒŒÇ‚É‚æ‚éƒp[ƒLƒ“ƒ\ƒ“•aƒ¿ƒVƒkƒNƒŒƒCƒ“d‡‘£i‹@\‚̉𖾠|
ûM–ì@’‰‘¥ |
”’“¡@–@“¹ |
2014 |
200ç‰~ |
iBj §ŠwŠñ•‹à
Žó“üŒ” |
38@Œ |
Žó“ü‹àŠz |
25,735,640@‰~ |
iAj Šw‰ïŠJÓ™
‹æ•ª |
ŽåÃE‹¤Ã‚Ì•Ê |
Šw‰ï–¼ |
ŠJÓú |
ŠJÃ’n |
‘“àŠw‰ï(’n•ûƒŒƒxƒ‹) |
ŽåÃŽÒ |
‘æ9‰ñ“à‰Èˆã‚ð–ÚŽw‚·ŽáŽèˆãŽt‚Ì‚½‚ß‚Ì‹³ˆçƒZƒ~ƒi[u“à‰ÈŠw‚Ì–¢—ˆ‚ð肤v |
2014.11.29 |
‹à‘ò |
iBj Šw‰ï‚ÌŽÀÑ
Šw‰ï‚Ì–¼Ì |
–ðE–¼ |
Ž–¼ |
“ú–{“à‰ÈŠw‰ï |
•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{“à‰ÈŠw‰ï |
–k—¤Žx•”•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{Á‰»Ší•aŠw‰ï |
à’c•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{Á‰»Ší•aŠw‰ï |
–k—¤Žx•”•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{ŠÌ‘ŸŠw‰ï |
•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{ŠÌ‘ŸŠw‰ï |
¼•”‰ï•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï |
–k—¤Žx•”•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{Á‰»Ší–ƉuŠw‰ï |
•]‹cˆõ |
’†–{ ˆÀ¬ |
“ú–{_ŒoŽ¡—Êw‰ï |
•]‹cˆõ |
à_–ì ’‰‘¥ |
“ú–{_ŒoŠ´õÇŠw‰ï |
•]‹cˆõ |
à_–ì ’‰‘¥ |
“ú–{_ŒoŠw‰ï |
‘ã‹cˆõ |
à_–ì ’‰‘¥ |
”F’è“à‰ÈŠw‰ïê–åˆã•”‰ï |
–k—¤Žx•”‘ã•\/–k—¤Žx•”–ðˆõ |
à_–ì ’‰‘¥ |
“ú–{Á‰»Ší•aŠw‰ï |
Šw‰ï•]‹cˆõ |
{“¡ O”V |
“ú–{Á‰»Ší•aŠw‰ï |
–k—¤Žx•”•]‹cˆõ |
{“¡ O”V |
“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï |
–k—¤Žx•”•]‹cˆõ |
{“¡ O”V |
“ú–{Á‰»Ší•aŠw‰ï |
–k—¤Žx•”•]‹cˆõ |
ª–{ •üK |
“ú–{ðŽqŒŸo‚ÆŽ¡—Êw‰ï |
•]‹cˆõ |
ŽR‘º C |
“ú–{”]_Œo’´‰¹”gŠw‰ï |
•]‹cˆõ |
ŽR‘º C |
“ú–{Á‰»Ší•aŠw‰ï |
–k—¤Žx•”•]‹cˆõ |
‘å’J ¹O |
“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï |
–k—¤Žx•”•]‹cˆõ |
‘å’J ¹O |
iCj ‚»‚Ì‘¼
ƒŽóÜ„ ·
*‹v•Û“c@‰ëŽj, ŽR‘º@C, _àV@•üŽq, *ŒÜ\—’@çH, *¼”ö@‰p–¾, *¬£@œA—º, *“ˆ“c@½ˆê˜Y, +‰Á“¡@—´, +‰¡ˆä@_Žj, *“à“c@Œ¤‘¢, *”nê@‹v•q: —Šw—Ö@Šw‘æ41ŠªŒ¤‹†˜_•¶Å—DGÜiŒö‰vŽÐ’c–@l@“ú–{—Šw—Ö@Žm‹¦‰ïj, 2015.03 ƒ•ñ“¹„ ·
à_–ì@’‰‘¥: g‚Ó‚‚¢‚̃hƒNƒ^[‘Š’kŽºhオŸŽè‚ɉñ‚èAŒû‚©‚ç˜Io, •Ÿˆä, 2014.04.17 ·
ŽR‘º@C: ƒGƒRƒmƒ~[ƒNƒ‰ƒXÇŒóŒQ@—\–hŒŸf, NHKƒjƒ…[ƒX‚¨‚͂悤“ú–{@iNHKŠâŽèj, 2014.05.11 ·
—Ñ@_Žk: gŒ³‹C‚ňケ‚¤h”]‘²’†‚ÌŽ¡—Â͈ê‚à‘‚, Œ§–¯•Ÿˆä, 2014.06.08 ·
ŽR‘º@C: ‹³ŒP‚ð¡‚Éc•Ÿˆä‹‰J10”N, ƒCƒ“ƒ^ƒrƒ…[, •ŸˆäƒeƒŒƒr@ƒX[ƒp[ƒjƒ…[ƒX, 2014.07.09 ·
ª–{@•üK: gŒ³‹C‚ňケ‚¤hŠÌ‘Ÿ‚ª‚ñ‚ÌÅVŽ¡—Ã, Œ§–¯•Ÿˆä, 2014.07.27 ·
ŽR‘º@C: ”ð“ɒiƒ{[ƒ‹ƒxƒbƒh, •Ÿˆä,
2014.08.28 ·
ŽR‘º@C: ЊQŽž‚Ì”ð“ïŠuƒXƒy[ƒXL‚v, Œ§–¯•Ÿˆä,
2014.09.08 ·
{“¡@O”V:
H.pyloriœ‹ÛŒã‚̃fƒBƒXƒyƒvƒVƒAÇó‚ÆBMI‚̕ω», Medical
Tribune, 2014.12.11 ·
ŽR‘º@C: •Ÿˆä‘åEŽR‘ºˆãŽt‚ª’ñ¥ ‚—îŽÒЊQŠÖ˜AŽ€–h‚°, “Ç”„,
2015.01.17 ·
ŽR‘º@C: ”íÐŽÒŽx‰‡‚ÌŒ®‚Í‘½•ª–ì˜AŒg, L“‡“y»ÐŠQ‚𓥂܂¦A”íÐŽÒŽx‰‡‚ÌÝ‚è•û‚ð’T‚éƒVƒ“ƒ|ƒWƒEƒ€‚ɂ‚¢‚Ä, ’†‘V•·,
2015.01.26 ·
ûM–ì@’‰‘¥: gŒ³‹C‚ňケ‚¤h‘–Œ‰Š, Œ§–¯•Ÿˆä, 2015.02.22 ·
ŽR‘º@C: ƒVƒŠ[ƒY‚ ‚·‚Ö”õ‚¦‚é@‚—îŽÒŒ©Žç‚èƒVƒXƒeƒ€, Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†‚ɂ‚¢‚Ä, NHK•Ÿˆä•ú‘—‹Ç,
2015.02.26 ·
ŽR‘º@C: ƒT[ƒrƒX•t‚«‚—îŽÒZ‘î “ü‹ŽÒ‚ÌŒ’NŠO‚©‚çŠm”F, •Ÿˆä,
2015.03.05 ·
ûM–ì@’‰‘¥: g”F’mÇ‚ðŽx‚¦‚é•Ÿˆä‚ÌŽ‹“_h‰º@’nˆæ‚Å•é‚ç‚·‚½‚ß‚ÉŒ§“àê–åˆã‚É•·‚, •Ÿˆä, 2015.03.26 |
iAj ‘E’nˆæ“™‚Ö‚ÌvŒ£
(1) R‹c‰ïEˆÏˆõ‰ïEŒö‰v–@lE‰ïŽÐ“™‚Ö‚ÌŽQ‰Áó‹µ
‹æ•ª |
‹@ŠÖEˆÏˆõ‰ï‚Ì–¼Ì“™ |
–ðE |
Ž–¼ |
ŠúŠÔ |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§“à‰Èˆã‰ï |
ŒÚ–â |
’†–{@ˆÀ¬ |
2011.04` |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§Œ’N•ŸŽƒ•” |
ˆÏˆõ |
’†–{@ˆÀ¬ |
2013.04.01`2015.03.31 |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§ˆãŽt‰ï, •ŸˆäŒ§ˆãŽt‰ïˆã—ÃVƒXƒeƒ€ˆÏˆõ‰ï |
ˆÏˆõ |
’†–{@ˆÀ¬ |
2013.08`2015.06 |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§’è”N—î”F’mÇŒŸfŒŸ“¢•”‰ï |
ˆÏˆõ |
à_–ì@’‰‘¥ |
2012` |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§‘–¯Œ’N•ÛŒ¯f—ÕñVR¸ˆÏˆõ‰ï |
ˆÏˆõ |
{“¡@O”V |
2012.06`2014.08 |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§‚ª‚ñŒŸf¸“xŠÇ—ˆÏˆõ‰ï |
ˆÏˆõ |
{“¡@O”V |
2012.10` |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§‚ª‚ñf—ØAŒg‹¦‹c‰ï, ˆÝ‚ª‚ñ’nˆæ˜AŒgƒpƒXESDƒ[ƒLƒ“ƒO‰ï‹c |
ˆÏˆõ |
{“¡@O”V |
2014.09` |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§Œ’N•ŸŽƒ•”’nˆæˆã—ÉÛ, ’nˆæˆã—ØAŒgƒVƒXƒeƒ€\’zŒŸ“¢‰ï |
ˆÏˆõ |
ŽR‘º@C |
2010.07` |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§•ŸˆäŒ’N•ŸŽƒƒZƒ“ƒ^[, •ŸˆäEâˆä’nˆæˆã—ØAŒgEÝ‘îˆã—Äi‹¦‹c‰ï |
ˆÏˆõ |
ŽR‘º@C |
2011.01` |
’n•ûŽ©Ž¡‘Ì |
•ŸˆäŒ§Œ’N•ŸŽƒ•” |
ê–å•”‰ïˆãˆõ |
ŽR‘º C |
2013.04.01`2018.03.31 |
Œö‰v–@l“™ |
“ú–{ŠwpU‹»‰ï |
ê–åˆÏˆõ |
’†–{@ˆÀ¬ |
2013.12.01`2014.11.30 |
‚»‚Ì‘¼ |
(ŽÐ)•ŸˆäŒ§ˆãŽt‰ï |
ˆÏˆõ |
’†–{@ˆÀ¬ |
2013.08.01`2015.06.30 |
‚»‚Ì‘¼ |
•ŸˆäŒ§Œ’N•ŸŽƒ•” |
ˆÏˆõ |
ûM–ì@’‰‘¥ |
2013.04.20`2015.04.19 |
‚»‚Ì‘¼ |
•ŸˆäŒ§ˆãŽt‰ï, •ŸˆäŒ§ˆãŽt‰ï—«ˆãŽt‘ÎôˆÏˆõ‰ï |
ˆÏˆõ |
ŽR‘º@C |
2013.08`2015.06 |
‚»‚Ì‘¼ |
•ŸˆäŒ§ˆãŽt‰ï, •ŸˆäŒ§ˆãŽt‰ï‚ª‚ñ“o˜^E”]‘²’†“o˜^ˆÏˆõ‰ï |
ˆÏˆõ |
ŽR‘º@C |
2013.08`2015.06 |
‚»‚Ì‘¼ |
•ŸˆäŒ§—§•a‰@, •ŸˆäŒ§—§•a‰@ˆã—Ãî•ñƒVƒXƒeƒ€XV‹Æ–±ˆÏ‘õ‚ÉŠÖ‚·‚éR¸ˆÏˆõ‰ï |
ˆÏˆõ |
ŽR‘º@C |
2015.02`2015.03 |
(2) ŽÐ‰ïl“™‚Ö‚ÌvŒ£‹y‚ÑŠwZ“™‚Ƃ̘AŒgE‹¦—Í‚É‚æ‚銈“®
‹æ•ª |
Šˆ“®–¼EŠˆ“®“à—e |
ŽåÃŽÒE‘ÎÛŽÒ“™ |
Ž–¼ |
ŒöŠJuÀ |
Žs–¯ŒöŠJuÀ ŠÌ‚ª‚ñ–o–ŃtƒH[ƒ‰ƒ€2014uƒCƒ}ƒhƒL‚ÌŠÌ‘Ÿ‚ª‚ñv, BŒ^ŠÌ‰Š‚Æ‚ª‚ñ |
(ˆêŽÐ)“ú–{ŠÌ‘ŸŠw‰ï, ˆê”Ê |
’†–{@ˆÀ¬ |
ŒöŠJuÀ |
Žs–¯ŒöŠJuÀ ŠÌ‚ª‚ñ–o–ŃtƒH[ƒ‰ƒ€2014uƒCƒ}ƒhƒL‚ÌŠÌ‘Ÿ‚ª‚ñv, ŠÌ‘Ÿ‚ª‚ñ |
(ˆêŽÐ)“ú–{ŠÌ‘ŸŠw‰ï, ˆê”Ê |
ª–{@•üK |
ŒöŠJuÀ |
‚“xê–åE‹Ælˆç¬, Ý‘îˆã—ÃvƒƒtƒFƒbƒVƒ‡ƒiƒ‹uÀ |
•Ÿˆä‘åŠw, ê–åE‹Æl, 130l |
*’·’Jì@”ü, ŽR‘º@C, *•“c@—L‹IŽq |
u‰‰EƒZƒ~ƒi[“™ |
lŠÔ‰ÈŠw“Á•Êu‹`, –¢—ˆˆã—Âɂ¨‚¯‚é—Ï—« |
Î쌧—§‹à‘òò‹u‚“™ŠwZ, ‚Z¶, 41l |
’†–{@ˆÀ¬ |
u‰‰EƒZƒ~ƒi[“™ |
âˆä’n‹æŠwpu‰‰‰ï, ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ɑ΂·‚鎡—Ã`ƒCƒ“ƒ^[ƒtƒFƒƒ“‚©‚çŒoŒûÜ‚Ö` |
âˆä’n‹æˆãŽt‰ïAƒuƒŠƒXƒgƒ‹Eƒ}ƒCƒ„[ƒYŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
’†–{@ˆÀ¬ |
u‰‰EƒZƒ~ƒi[“™ |
‘æ173‰ñ‰œ‰zŠwpu‰‰‰ï, ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ɑ΂·‚鎡—Ã`ƒCƒ“ƒ^[ƒtƒFƒƒ“‚©‚çŒoŒûÜ‚Ö` |
‘å–ìŽsˆãŽt‰ïAŸŽRŽsˆãŽt‰ïAƒuƒŠƒXƒgƒ‹Eƒ}ƒCƒ„[ƒYŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
’†–{@ˆÀ¬ |
u‰‰EƒZƒ~ƒi[“™ |
‘Ûƒ]ƒ“ƒ^•Ÿˆäƒ]ƒ“ƒ^ƒNƒ‰ƒu@‘æ24‰ñŒ’Nu‰‰‰ï, ’m‚Á‚Ä‚¨‚«‚½‚¢u”F’mÇ—\–h‚Ɣǂµ‚½•û‚ւ̑Έ–@v |
‘Ûƒ]ƒ“ƒ^•Ÿˆäƒ]ƒ“ƒ^ƒNƒ‰ƒu, ˆê”Ê, 110l |
à_–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
—ä–k”F’mÇŽ¾Š³ˆã—ÃZƒ“ƒ^[Œ¤C‰ïuÅ‹ß’–Ú‚³‚ê‚é”F’mÇ ”F’mÇ‚ÌV‚µ‚¢“WŠJv, Å‹ß’–Ú‚³‚ê‚é”F’mÇ |
—ä–k”F’mÇŽ¾Š³ˆã—ÃZƒ“ƒ^[E•ŸˆäŽsE•ŸˆäŽsˆãŽt‰ï, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
”F’mǃtƒH[ƒ‰ƒ€ in •Ÿˆä, •ŸˆäŒ§’è”N—f‚ÌŽæ‚è‘g‚Ý |
•ŸˆäŒ§“à‰Èˆã‰ïA¬–ì–ò•iH‹ÆŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
ŽÐ“àŒ¤C‰ï, PDAADŽ¾Š³Ž¡—Âɂ‚¢‚Ä |
ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}Š”Ž®‰ïŽÐ, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
¢ŠEƒAƒ‹ƒcƒnƒCƒ}[ƒf[‹L”OƒCƒxƒ“ƒgu’m‚Á‚ĂĈÀS!”F’mÇv, ”F’mÇ‚Æ“œ”A•a |
•ŸˆäŒ§AŒö‰vŽÐ’c–@l”F’mÇ‚Ìl‚ƉƑ°‚Ì‰ï •ŸˆäŒ§Žx•”, ˆê”Ê |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
•ŸˆäƒNƒŠƒjƒJƒ‹ƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒZƒ~ƒi[, ƒAƒŠƒZƒvƒg‚ÌV‚½‚È“WŠJ |
ƒG[ƒUƒCŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
ƒwƒ‹ƒXƒAƒbƒvƒZƒ~ƒi[in•Ÿˆä, ’m‚Á‚Ä‚¨‚«‚½‚¢!”F’mÇ‚Ì—\–h–@‚ƑΈ–@ |
•Ÿˆä•ú‘—(ŽåÃ)EƒNƒXƒŠ‚̃AƒIƒL(‹¤Ã), ˆê”Ê |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
Šwpu‰‰‰ï, ƒAƒŠƒZƒvƒg‚ÌV‚½‚È“WŠJ |
ƒG[ƒUƒCŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
âˆä’n‹æ ”F’mǃZƒ~ƒi[, ”F’mÇŽ¡—Öò‚ÌŽg‚¢•û‚ɂ‚¢‚Ä |
âˆä’n‹æˆãŽt‰ï,‘æˆêŽO‹¤Š”Ž®‰ïŽÐ, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
‘æ2‰ñN-Pƒlƒbƒgƒ[ƒNŒ¤‹†‰ï, ”F’mÇf—Âɂ¨‚¯‚éÅV‚̘b‘è‚ɂ‚¢‚Ä |
N-Pƒlƒbƒgƒ[ƒNŒ¤‹†‰ï/‘æˆêŽO‹¤Š”Ž®‰ïŽÐ, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
‚©‚©‚è‚‚¯ˆãŽÀ‘HŒ¤Cƒfƒ‚Œ¤C, MMSE‚ðŽÀÛ‚És‚¢Œ‹‰Ê‚ð•ªÍ |
—ä–k”F’mÇŽ¾Š³ˆã—ÃZƒ“ƒ^[, ê–åE‹Æl |
ûM–ì@’‰‘¥ |
u‰‰EƒZƒ~ƒi[“™ |
‘æ4‰ñ•ŸˆäŠÌ‘Ÿ‰h—{ƒtƒH[ƒ‰ƒ€, ŠÌ«”]LJ•¹ŠÌd•ÏŠ³ŽÒ‚ɑ΂·‚éƒJƒ‹ƒjƒ`ƒ“‚Ì—L—p«‚ÌŒŸ“¢ |
‘å’Ë»–òŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
ª–{@•üK |
u‰‰EƒZƒ~ƒi[“™ |
‘æ24‰ñ@‹ž“s”]_ŒoE–¬ŠÇ’´‰¹”gƒZƒ~ƒi[, À’· |
ƒTƒmƒtƒBŠ”Ž®‰ïŽÐ, ê–åE‹Æl |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
Ý‘îf—ÂƗհƒXƒRƒA, Ý‘îf—ÂƗհƒXƒRƒA |
•ŸˆäŒ§ŠÅŒì‹¦‰ï, ê–åE‹Æl, 40l |
*‘O“c@^O, ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
•½¬26”N“x@‚悤‚±‚»æ”y, ‚Z¶‚ÌE‹ÆŠÏˆç¬‚ð–Ú“I‚Æ‚µ‚½u‰‰ |
•ŸˆäŒ§—§“¡“‡‚“™ŠwZ, ‚Z¶ |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
“ú–{_ŒoŠw‰ï‘æ11‰ñ¶ŠU‹³ˆçƒZƒ~ƒi[, ŽÀKuŽt@“ú–{_ŒoŠw‰ï‘æ11‰ñ¶ŠU‹³ˆçƒZƒ~ƒi[@Hands|on6@’´‰¹”gièò“®–¬ƒGƒR[j |
“ú–{_ŒoŠw‰ï, ê–åE‹Æl |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
–k—¤’nˆæICT@ƒCƒmƒx[ƒVƒ‡ƒ“ƒZƒ~ƒi[, SCOPEŒ¤‹†ŠJ”¬‰Ê”•\@Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†ŠJ” |
‘–±È–k—¤‘‡’ÊM‹Ç, ˆê”Ê |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
‚Ó‚ê‚ ‚¢‚í‚©‚ΉïŠwK‰ï, ‚‚Ȃ²‚¤I”]‘²’†‚Ì—Ö |
JA•ŸˆäŽs‚Ó‚ê‚ ‚¢‚í‚©‚Ήï, ˆê”Ê |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
Fukui Stroke Network Meeting, u‰‰@SŒ´«”]Çð‚Ìŋ߂̘b‘è |
“ú–{ƒx[ƒŠƒ“ƒK[ƒCƒ“ƒQƒ‹ƒnƒCƒ€Š”Ž®‰ïŽÐ, ê–åE‹Æl |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
‘æ19‰ñŽ–—ጤ‹†•”‰ï@ƒwƒ‹ƒXƒPƒAƒCƒmƒx[ƒVƒ‡ƒ“ƒtƒH[ƒ‰ƒ€iHCIF), Ž–—ᔕ\@SCOPEŽÀØŽ–‹Æ‚ɂ‚¢‚Ä@|Ý‘îˆã—ÂƉîŒì‚ׂ̈̃Aƒ‰[ƒ€ƒAƒhƒoƒCƒU[Žx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†ŠJ”[ |
ƒwƒ‹ƒXƒPƒAƒCƒmƒx[ƒVƒ‡ƒ“ƒtƒH[ƒ‰ƒ€@iHCIFj, ê–åE‹ÆlEˆê”Ê |
ŽR‘º@C |
u‰‰EƒZƒ~ƒi[“™ |
•½¬26”N“x@•ŸˆäŒ§‰îŒìŽx‰‡ê–åˆõê–匤CEXVŒ¤CiŒoŒ±ŽÒj‰Û’ö‡T, ‚—îŽÒ‚ÌŽ¾•a‚ƑΈ‚¨‚æ‚ю厡ˆã‚Ƃ̘AŒg |
ŽÐ‰ï•ŸŽƒ–@l@•ŸˆäŒ§ŽÐ‰ï•ŸŽƒ‹¦‹c‰ï, ê–åE‹Æl |
ŽR‘º@C |